 
 KEYS TO STAYING SHARP  
 
 
 
Interventions to Attenuate Cognitive Decline  
     
Supported by:  
 
The National  Institute on Aging  
 
R01 AG056428 
 
Principal Investigator:  Jerri Edwards  
      

 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 2 of 58  
 Table of Contents  
1 SYNOPSIS  ..................................................................................................................................................... 5 
1.1 Study Title  ............................................................................................................................................................................... 5 
1.2 Objectives  ................................................................................................................................................................................ 5 
1.3 Design  ...................................................................................................................................................................................... 5 
1.4 Outcomes  ................................................................................................................................................................................. 5 
1.5 Interventions and Duration  ..................................................................................................................................................... 5 
2 STUDY OBJECTI VES  ................................ ................................ ................................ ............................  7 
2.1 Primary Objective  ................................................................................................................................................................... 7 
2.2 Secondary Objectives  .............................................................................................................................................................. 7 
3 BACKG ROUND  ................................ ................................ ................................ ................................ ...... 8 
4 STUDY DESIGN  ................................ ................................ ................................ ................................ .... 11 
5 SELECTION AND ENROLLMENT OF PARTICIPANTS  ................................ ................................  11 
5.1 Inclusion Criteria  .................................................................................................................................................................. 11 
5.2 Exclusion Criteria  .................................................................................................................................................................. 11 
5.3 Enrollment Procedures  .......................................................................................................................................................... 13 
5.4 Describe consent procedures.  ................................................................................................................................................ 14 
5.5 Describe the procedure for obtaining intervention group assignment  ................................................................................. 15 
5.6 STUDY INTERVENTIONS  .................................................................................................................................................. 16 
5.7 Interventions, Administration, and Duration ....................................................................................................................... 16 
5.7.1  Prohibited Interventions  ........................................................................................................................................................ 16 
5.8 Adherence Assessment  .......................................................................................................................................................... 17 
6 CLINICAL AND LABORATORY EVALUATIONS  ................................ ................................ ..........  18 
6.1 Timing of Evaluations  ........................................................................................................................................................... 21 
6.1.1  Pre-Randomization Evaluations  ............................................................................................................................................ 22 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 3 of 58  
 6.1.2  Intervention Phase .................................................................................................................................................................  22 
6.1.3  Post-Test  ............................................................................................................................................................................... 23 
6.2 Overall Project Timeline  ....................................................................................................................................................... 23 
6.3 Intervention Discontinuation Evaluations Rete ntion  ............................................................................................................ 24 
6.3.1  Retention  ............................................................................................................................................................................... 24 
6.3.2  Documentation of MCI or dementia  ..................................................................................................................................... 25 
6.3.3  Concomitant Treatments  ....................................................................................................................................................... 25 
6.3.4  Study Intervention Modifications  ......................................................................................................................................... 25 
6.3.5  Measures  ............................................................................................................................................................................... 25 
6.3.6  Questionnaires  ...................................................................................................................................................................... 30 
7 MANAGEMENT OF ADVERSE EVENTS  ................................ ................................ .........................  31 
8 CRITERIA FOR PARTICIPANT DISCONTINUATION  ................................ ................................ .. 31 
9 STATISTICAL CONSIDERATIONS  ................................ ................................ ................................ .. 31 
9.1 General Design Issues  ............................................................................................................................................................ 31 
9.2 Primary Objectives  ................................................................................................................................................................ 31 
9.2.1  Primary outcomes  .................................................................................................................................................................  32 
Secondary Objectives  ..................................................................................................................................................................... 32 
9.3 Sample Size  ............................................................................................................................................................................ 32 
9.4 Data Monitoring .................................................................................................................................................................... 33 
9.5 Interim Data Analyse s ........................................................................................................................................................... 33 
9.6 Final Data Analyses  ............................................................................................................................................................... 34 
9.7 Sensitivity Analyses  ............................................................................................................................................................... 36 
9.8 Exploratory Subgroup Analyses  ........................................................................................................................................... 36 
10 DATA COLLECTION, SITE MONITORING, AND ADVERSE EXPERIENCE REPORTING  .... 38 
10.1 Records to Be Kep t ................................................................................................................................................................ 38 
10.2 Data Management  .................................................................................................................................................................  38 
10.2.1  Clinical site responsibilities in data collection and management.  .................................................................................... 38 
11 QUALITY ASSURANCE  ................................ ................................ ................................ ......................  39 
11.1 Adverse Experience Reporting  .............................................................................................................................................. 40 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 4 of 58  
 11.2 Follow -up for Adverse  Events  ............................................................................................................................................... 41 
11.3 Safety Monitoring  .................................................................................................................................................................. 41 
11.4 Confidentiality  ....................................................................................................................................................................... 41 
11.5 Study Modification/Discontinuation ..................................................................................................................................... 41 
12 REFERENCES  ................................ ................................ ................................ ................................ ...... 44 
 
13. DATA AVAILABILITY 50 
 
14. RESULTS  50 
 
14.1 Participant characteristics by randomized arm and cognitive status . 54 
 
14.2 The effects of random ization to  piano training as compared to music listening from baseline to post-
training across composite outcomes of central auditory processing, cognition, and everyday function.   55  
 
14.3 Effect sizes for piano training relative to music listening across composite outcomes and assessments for 
the analytic sample overall, among those adherent, and by cognitive status . 57 
 
15. CONSORT CHART  59 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 5 of 58  
 1 SYNOPSIS  
1.1  Study Title  
Interventions to Attentuate Cognitive Decline :  Keys to Staying Sharp.  
1.2  Objec tives 
 
The prim ary objectives are:  
 
• To examine the efficacy of piano training to improve central auditory processing (CAP), cogni tion, and 
everyday function among older adults  with and without mild cognitive impairment (MCI) .  
 The secondary obj ectives are:
 
• To examine th e moderating effects of MCI on piano training effic acy.   
• To explore mediators of intervention effects.  
 
1.3  Design  
The design is a two arm randomized clinical trial examining the efficacy of piano training relative to music lis-tening instruct ion to improve CAP, cognition, and everyday function in older adults with and without MCI 
across two time points (baseline and immediate post- test). This is a phase II trial to test the efficacy of promis-
ing behavioral intervention (i.e., piano training) i n a research setting. The primary outcome of interest is cogni-
tion
1. 
 
1.4  Outcomes  
 
We will quantify the effects of piano training on CAP, cognition, and everyday functional performance.  
 CAP  measures will include :  Time Compressed Speech  65% , Words -in-Noise, Dichotic Digits Test, Dicho tic 
Sentence Identification, and Adaptive Test s of Temp oral Resolution. 
 Cognition measures will include :  Verbal Fluency Test (phone mic fluency, cat egory fluency, and category 
switching ), Trail Making  Test, and Digit Coding. 
 Everyday Function measures will include :  Timed Instrumental Activities of Daily Living and Test of Everyday 
Attention . 
 
1.5  Interventions and Duratio n 
 Piano Traini ng.  Piano training will consist of basic piano technique, dexterity exercises, piano liter ature, and 
music theory.  At each bi -weekly training session, participants will be  trained in groups and will be  expected to 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 6 of 58  
 perform all te chnique (sc ales/finger dex terity exercises), piano repertoire (Alfred Basic All -in-One Method), 
and complete music theory assignments.  Each class session will be stru ctured with a short review  followed by 
an intense focus on new skill development (e.g., s cales; chor d progressions)  and concept formation (e.g., inte r-
vals).  At least one five -minute break will occur in each session.   
 
Music Listening Instruction Condition .  Participants randomized to the music listening instruction  condition 
will engage in m usic listen ing and appreci ation .  The participants read about, listen to, view diagrams of, and 
answer questions about the music.  Each lesson  will cover chapters from  Music Listening Today  over 90 
minutes.   Each lesson will be structured as follows:  Overv iew of chap ter material an d group listening activity, 
participants  read over c hapter on their own, active  listening activity, five question quiz , overview of next chap-
ter material and group  listening activity , participants read over chapter on their own, a ctive liste ning activity, 
and five question quiz .  At least one five -minute break will occur in each session.  This structure is equivalent to 
the switching between ensemble/individual approach to teaching in the piano training condition.   The two trainin g conditions  will be equiv alent in terms of frequency  and duration of each session (90 min/day, 
two days/wk, 10 weeks)  and social contact (led by trainer and conducted in groups of up to 10 persons) .  Both 
conditions will be described as “music training”.   
 Sample S ize and Populat ion 
 Our goal is to have up to 360 participants complete the study.  Individuals with normal cognition and those with 
a clinical diagnosis of MCI  will be recruited for this study.  Inclusion and exclusion criteria are detailed bel ow. 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 7 of 58  
 2 STUDY OBJECTIVES  
2.1  Primary Objective  
The primary objective is:  
 
• To examine the efficacy of piano training to improve CAP, cognition, and everyday function among 
older adults  across  baseline to immediate post- test.  We will assess the effects of pian o training (in ter-
vention) as compared to music lis tening instruction  (active control)  on CAP, cognition, and everyday 
function.  The primary outcome of interest is cognition.  
 
Hypotheses:  The piano training group will outperform the music  listening  instruct ion group on 
measures of C AP, cognition, and everyday function immediately post- intervention.  
 
Rationale : The efficacy of a novel intervention will be established relative to an active control group.  
There is compelling evidence that CAP deficits contrib ute to cognitive difficulties  2-5 and are a risk fac-
tor for dementia  3, 6, 7.  We propose that enhancing CAP may be particularly important to improve cogni-
tive function.  Formal music training is longitudinally associated with  enhanced C AP and successf ul 
cognitive aging.  Piano training is a feasible, potentially effic acious intervention to improve older adults’ 
CAP and cognition.  
 
2.2  Secondary Objectives  
The secondary objectives are:  
 
• To examine the moderating effects of MCI  on piano trai ning efficacy.  Moderating effects of MCI status 
will determine if piano training is effective for older adults with and/or without MCI.  
  Rationale:  It is possible that piano training is effective prior to cognitive decline, but not in those w ith 
MCI.  It is also possi ble that cognitive and/or functional abilities may be differentially enhanced among 
those with and without MCI.  Delineating the effects of piano training among those with and without MCI will discern who is most likely to benefit from piano training, and for what specific outcomes.  We 
do not have a directional hypothesis for this objective.  
 
• To ex plore mediators of intervention effects.  
 Hypothesis : Grounded in theory
8 and prior research9-11, we hypothesize that piano training will improve 
CAP and cognitive performance, leading to functional improvements.  We expect that enhanced CAP will mediate cognitive gains.  We further hypothesize that cognitive gains will mediate fun ctional im-
prove ments.   
 Rationale : Crucially, we must discern the underlying mechanisms of effective interventions in order to 
maximize training gains.  
 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 8 of 58  
 3 BACKGROUND  
 
Cognitive impairment and dementia are the most feared signs of aging12-14.  In addition to the obvious 
health and quality- of-life ramifications for older adults, there are high economic costs (e.g., subsidizing nursing 
home care; lost productivity of family caregivers), when older adults can no longer live independently15.  Thus, 
preve ntion of cognitive and subsequent functional decline among older adults is of critical importance to public 
health.  Dementia is the most expensive medical cond ition and incre ases in prevalence with age16, 17.  Given that 
older adults are the fastest growin g segment of the population18, the prevalence of dementia (and its precur sor, 
mild cognitive impairment- MCI) has been increasing rapidly19.  Therefore, finding effective strategies for inte r-
vention to prevent or delay deme ntia is imperative t o improve publi c health.  The contribution of the proposed 
research is expected to be the identification of a novel and effective cognitive intervention to counter age -
related cogn itive and functional decline, which could potentially delay dementia onset.  We will elucid ate the 
underlying mechanisms of effective interventions to facilitate maximizing cognitive gains and improving eve-
ryday function.  The contribution of this research will be significant in that if an intervention could de lay the 
onset of Alz heimer’s diseas e by only one year, there would be about 9.2 million fewer cases of the di sease in 
205020, substantially lessening the burden.  Results will inform subsequent research and clinical practice by f a-
cilitatin g the design and implementation of effective interventions to atten uate cognitive decline and thereby 
improve public health.  
Mild Cognitive Impairment (MCI).  Cognitive status has been conceptualized on a continuum from 
normal cognition to clini cally ascer tained dementia such as Alzheimer’s disease.  MCI represents a transitional 
phase between normal aging and dementia21, 22.  MCI patients have higher risk of developing dementia12, 23 with 
conversion to dementia of ~12% per year23 (although not all individuals progress across this continuum).  
Among individuals with and without MCI, cognitive interventi ons may enh ance cognition and maintain ever y-
day functioning, thereby delaying dementia onset24.  A paucity of  research and methodologic al inadequacies 
have limited the implementation of effective cognitive interventions in MCI25, 26.  One avenue to enhan ce cogn i-
tion is the facilitation of central auditory processing ( CAP ) at initial perceptual stages5, which may potentially 
be achieved by piano training.  Our scien tific premise is that pian o training will enhance CAP, resulting in i m-
proved cognition and subsequently everyday function, thereby delaying the onset of dementia.  The primary outcome of interest is cognition.  
Central Auditory Processing (CAP).  One early  indicator of cognitive im pairment is impaired auditory 
processing. Auditory processing and decoding of sound occurs at multiple levels of the central auditory nervous system.  Central auditory processing dysfunction is characterized by deficits in using s upra-thresh old sound, 
such as poor monaural speech -in-noise perception, binaural speech processing, sound localization and lateral i-
zation, and auditory processing speed 
27.  When CAP  is impaired, information received  by the cogniti ve systems 
is distorted and incomplete, causing information processing difficulties. Auditory processing thus requires greater cognitive resources, negatively affecting memory and executive function 
8.  Decades of research have 
established that CAP is fun damentally linked with memory and executive functioning4, 5, 28, 29, which are the 
primary deficits in MCI and de mentia30, 31.  In su pport of this premise, CAP longitudinally predicts MCI and 
dementia such as Alzheimer’s disease32-34.  Prior research ( e.g., 35, 36) and our pilot data confirm that measures 
of CAP are strong, independent predi ctors of cognitive function (e.g., memory, execut ive function), and that 
adults with MCI show significant CAP deficits37, 38.  Deficits in CAP are multifaceted and  represented by diffi-
culties with, for example, auditory speed of processing, monaural speech -in-noise recognition, binaural speech 
processing, sound localiz ation and lateralization, and auditory pattern recognition5, 39.  Note that auditory speed 
of processing, a leading indicator of cognitive aging, is one of the key el ements of CAP40, as adequate sensory 
functioni ng is funda mental for norm al speed of processing41.  When CAP is impaired, information received by 
the cognitive systems is distorted and incomplete, causing information processing difficulties.  Auditory pr o-
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 9 of 58  
 cessing thus requires greater cognitive resources, negatively affecting memory and executive function8.  There-
fore, impaired CAP impedes cognitive performance41-45.  In addition to behavioral data, neuroanatomical evi-
dence documents that deficits in CAP46 are related to anterior temp oral lobe atrophy and reduced glucose me-
tabolism46-50, brain changes evident in MCI and Alzheimer’s disease51.  Neuroimaging further indicates a link 
between sensory function and cortical integrity, and that decreased volume in the auditory cortex cas cades to 
affect higher -order cognitive processing52-54.  In older adults, difficulties with CAP are associated with modified 
patterns of neural activation as well as with reduced gray matter volume in the auditory cortex.  Wong et al. and 
others55, 56 demonstrated that older adults show less activation in the auditory cortex and increased activation in 
the prefrontal cortex to perform cognitive tasks due to declines in CAP.  
Although CAP is a strong longitudinal predictor of cognitive decline, MCI, and dementia3, 34, 35, 57, prior 
research has not examined the effects of interventions targeting CAP on functional abi lities of older  adults with 
and without MCI.  Re -establishing and/or maintaining adequate CAP may be the first crucial step in efforts to 
improve cognitive abilities of older adults.  Given that multiple studies have shown music experience is strongly associated with better CAP
58-61, it is likely that piano training enhances CAP, leading to better cognition  (See 
Piano Training Rationale  below).  
Theoretical Background.  We hypothesize that improving brain function at early perceptual levels (i.e., 
CAP) may be optimal to attenuate cognitive and functional decline and potentially curb dementia prevalence.  This premise is grounded in the information degradation
8 theory.  The information degradation theory8, 62 posits 
that age- related ch anges in the brain cause i nitial sensory/perceptual processing errors that lead to difficulties 
with downstream information processing (i.e., CAP) and cognition (i.e., memory/executive function).  Accor d-
ing to this and similar theories, neurophysiological decline leads to reduced brain efficiency such that the speed and/or quality of processing (e.g., fidelity of representations, speed of neural transmission) is impaired due to poor perceptual encoding.  Thus, cognitive interventions should target improving initial pe rceptual proces sing 
(i.e., CAP) such that cognition can improve
63.  Accordingly, cognitive interventions that target basic perceptual 
processing may be most effective.  Furthermore, cognitive gains will be mediated by improvements in perce p-
tual processing (i.e., CAP).  Our recent analyses support this assertion, indicating that intervention targeting perceptual processing is more effective to curb dementia prevalence than other approaches
64.  The proposed 
study will advance the field by examining CAP as a mechanism of piano training.  
Piano Training Rationale.  Engagement in learning challenging new skills, such as learning to play the 
piano with training , is a promising cognitive intervention approach that is likely more effective than cognitive 
stimulation65.  Piano training can be defined as systematic sequential instruction to acquire piano skills that in-
cludes technique (scales/arpeggios/chords), music theory, and piano repertoire.  Verghese et al. observed that older adults who reported playing musical instruments were 69% less likely to develop dementia
66.  Increasing  
neuroscience evidence ind icates positive, longitudinal associations of music training with e nhanced structures 
and function in the brain67, 68.  Thus, music trainin g (piano training, in particular) has been proposed as a viable 
means to attenuate age-related cognitive decline69, 70.  Piano training may be an efficacious cognitive interven-
tion because it requires the simu ltaneous coupling of sensory processing, motor skills, and complex cognitive 
operations to be execu ted with temporal precision71.  We propose that piano training is a promising cognitive 
intervention be cause:  
a- Piano training enhances CAP.  Our central premise is that improving CAP ma y be the first crucial 
step to augment older adults’ cognition.  Numerous studies ins dicate that music experience is strongly associat-
ed with better CAP ( e.g., 58, 59-61).  CAP is likely enhanced by piano training due to the multicomponent de-
mands on complex temporal, sequential, and sensorimotor processing.  Correl ational studies indi cate superi or 
CAP for adults with formal music training compared to non- musicians72-74.  Further, Co -I Lister’s studies show 
that adult musicians have enhanced CAP, indicated by faster neurophysiological processing of sound, than their 
nonmusician counterparts9, 75.  Similarly, older musicians do not show age- related neural  timing del ays, indica t-
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 10 of 58  
 ing better CAP76.  Zendel and colleagues also demonstrated that CAP (i.e., auditory processing speed and 
speech -in-noise perception) is less suspectible to age- related decline in musicians59.  We propose to experimen-
tally examine the effects of piano training on older adults’ CAP in a RCT.   
b- Piano training enhances brain structures and function.  Epidemiological data show that musi c 
training is a ssociated with enhanced structures and function of the brain.  Scientists have hypothesized that pi-
ano training engages frontostriatal cerebellar circuits, including the motor cortex and basal ganglia, and will 
thus result in cognitive impro vements among older adults71, 77, 78.  Resear ch demonstr ates that long -term piano 
training is associated with greater activation in the cerebellum, an area associated with higher cognition (e.g., 
executive function)79.  Pianists show higher white matter integrity and greater gray matter density in motor ar e-
as of the brain than non- musicians79.  Neuroimaging research indi cates speci ficity in struc tural brain differences 
subsequent to piano training80.  Giv en that piano training is longitudinally associated with improved brain struc-
tures and function, it may attenuate age- related cognitive decline.  
c- Piano training enhances cognition.  Piano training is associated with improved cognitive perfor-
mance81, 82, 83-85.  Hanna-Pladdy and Gajewski demonstrated that as compared to non- musicians matched on age 
and education, older adult musicians performed better on memory (letter number sequencing, verbal learning 
test ds=0.47-0.53) and executive function measures (phonemic fluency d =0.59)86.  Musical training was a 
stronger predictor of older adults’ cognitive pe rformance than lifestyle activities87.  Seinfeld an d colleague s 
found that older adults randomized to piano training showed improved speed of processing ( d=0.71) and execu-
tive function ( ds=1.70-1.85)67.  Co -I Bugos published two pilot randomized trials  indicating  small to medium 
effects of piano training relative to controls for improved speed of processing and executive function.  I m-
provements in speed of processing were sustained three months after training (for details, see Preliminary 
Studies -Piano Training  below).  Combined with our pilot study, these data demonstrate enhanced speed of 
processing and executive function among older adults subsequent to piano training relative to controls81, 82.  
d- Piano training enhances older adults’ mood and quality of life.  In our experience, older adults are 
eager to participate in piano training studies and find the experience to be enjoyable.  Sei nfeld and colleagues 
found that older adults completing piano training reported less depression, improved mood, and better quality of 
life67.  Piano training may be a more enjoyabl e activity than  other types of cognitive intervention.  Further, pi-
ano training could be immediately implemented in the community if it is eff icacious.  
In summary, we chose piano training because it is a novel cognitive engagement approach that shows 
promi se to enhance C AP and cognition.  Although prior epidemiological research and our pilot studies indicate 
the potential efficacy of piano training81, 82, 83-85, statistically powered experimental studies are lacking.  Thus, 
we propose to examine the efficacy of piano training in a pha se II randomized trial . Per Onken’s model of be-
havioral interventions, we are examining efficacy in a research setting1.   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 11 of 58  
 4 STUDY DE SIGN  
 
A randomi zed clinial trial ( RCT ) with two arm s (piano training and music listening instruction ) across two lev-
els of cognitive functioning (cognitively intact older adults with and without MCI) will be rigorously conducted over three proje ct years.   Potentially eligible participants will complete  telephone screening, in -person baseline , 
and if needed, a clinical  assessment  to diagnos e MCI , will be randomized to complete piano-  or music listening 
instruction , and will complete immediate post- training a ssessments.   This is a phase II trial to test the efficacy of 
a promising behavioral intervention (i.e., piano training) in a research setting
1. 
 
5 SELECTION AND EN ROLLMENT OF PARTICIPAN TS 
5.1  Inclusion Criteria  
 Inclusion criteria will be:   
• aged 60 years or older  
 
• willingness to provide informed consent  
 
• willingness to complete up to 23 study visits at USF including attending in- lab interve ntion two t imes a 
week for  a three- month period with the goal of completing 20 sessions.  
 
• ability to speak and understand English 
 
• Montreal Cognitive Assessment score of 20 or higher (score 20 to 30 inclusive)  
 
• intact vision (binocular near visual acuity of 20/50 or better tested  with a standard near visual acuity 
chart)  
 
• adequate hearing acuity (no greater than a moderate hearing loss [ thresholds <70 dB HL] in the mid-
frequency range  [ 1000, 2000 Hz] in at least one ear as determined by a standard pure t one hearing eva l-
uation)  
 
• Music Reading Assessment score of 18  or lower (score 0 -18 inclusive)  
 
• ability to understand study procedures and comply with them for the length of the study in the tester’s 
opinion (and other study personnel opinion who interact w ith participant, such as t he study physician)  
 
5.2  Exclusion Criteria 
 Exclusion criteria will be:   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 12 of 58  
  
• moderate or worse depressive symptoms (GDS short form score >=5)    
 
• previous participation in USF Cognitive Aging Lab or Music Research and Testing lab1 intervention 
studies  
 
• previous participation in 10 or more hours of a computerized cognitive intervention computer programs 
(e.g., Lumosity, Posit Science Brain Fitness, InSight, or Brain HQ; Lace, CogMed, CogniFit, Happy 
Neuron, Dakim, DriveSharp or Sta ying Sharp by A ARP programs)  
 
• currently enrolled in another research study 
 
• planning on being away for two or more weeks during the next five months (recruit later)   
 
• undergoing chemotherapy or radiation treatment or planning surgeries or other procedures requiring a n-
esthesia within the next five months (recruit later)   
 
• four or more years of formal music training  such as private lessons or group lessons on a specific i n-
strument  
 
• ability to read music on two or more of the following clef s: Treble clef, Bass cl ef, Alto cl ef 
 
• four or mor e years of playing any one musical instrument  
 
• currently practicing or participating in any music activities - such as music performance or m usic reading 
or music lessons  or music related courses  
 
• difficulty and pain in moving hands or finger s, or neuropathy (e.g., numbness or tingling)  affecting 
hands , which interferes with the ability to use a keyboard2, or tremor in either hand, or missing any fi n-
ger or portion of a finger  
 
• self-reported diagnosis of dementia , stroke , serious bra in injury or neurological disorder  
 
• diagnosed by a physician or nurse with a TIA that occurred within the last 18 months   
 
• inability or unwillingness to give written informed consent at baseline  
 
• Clinical Dementia Rating Scale score of 1 or greater  
 
• Clinic al diagnosi s of dementia o r other disorder that in the study physician’s opinion would limit the 
persons ability to participate in the study or  benefit from the  interventions  
 
 
1 Although the “Music Research and Testing Lab” was omitted from version 1, thi s criteria was included in telephone screening from 
the study onset.  Potential participants were excluded if they r eported prior participation in Music Research and Testing Lab studies.  
2 We added this clarification, “that interferes with ability to use a k eyboar d” to the screening process . 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 13 of 58  
 5.3  Enrollment Procedures  
Participants will primarily be recruited through  the comm unity, the Cognitive and N europhysiology of Aging 
Lab registry , and mailing list of older adults residing in the area.  We may  also use the  Byrd Alzheimer’s Inst i-
tute Community -Based Memory Screening program  and the Department of Psychiatry and Behavioral Neur o-
sciences Memory Disor ders Clinic  (MDC) to enroll partic ipants in the study.   
 
Recruitment  and enrollment  will occur across  a pilot and five  or six  replicates .  Pilot replicate data will only be 
included in interim or final analyses if no significant changes to the study proce dures or this protocol are made 
after the pilot replicate is completed.  Any changes to the protocol will be noted with the effective date and jus-tification.    Throughout the study period at least one Research Assistant in the Co gnitive  and Neurophysiology of  Aging 
Lab will ma ke recru itment phone calls and answer  potential participant emails/calls.  Individuals who have e x-
pressed interest in our research will be telephone screen ed (i.e., inclusion/exclusion que stionnaire) by l ab staff.  
The study script should be followed for describing the study and answering any participant questions.  Scree n-
ers will emph asize to the participants that they are committing to complete up to 23 in -person study visits (i.e., 3 
testing sessions and 20 inte rventi on sessions) over the next five months.  Once eligibility and interest has been 
assessed, the final outcome is  coded .  The final recruitment outcome will be coded as 1) Scheduled; 2) Not 
Scheduled and Will Not Try Again; or 3) Not Scheduled, Wil l Try Again.  
 If the parti cipant is not eligible because they are  planning on being away or unavailable for more than 2 weeks 
in the next 5 months, or a re planning on having major surgery or undergoing any type of anesthesia, chemothe r-
apy, or radiation tre atment in the next 5 months , we will attempt to recruit them for the next replicate.   
 The study coordinator will oversee recruitment and serve as a primary contact for study pa rticipants.   
 
Those deemed initially eligible from telephone screening will c omplete an in -person scree ning at the Cognitive 
and Neurophysiology of Aging Lab.  This in- person screening will include the Montreal Cognitive Assessment  
(MoCA), Geriatric Depression Scale, vision and hearing screenings as well as the Music Reading A ssessment 
(MRA) to further conf irm eligibility  (See Inclusion/Exclusion above for details) .  
 Those potentially eligible  based on completion of these measures  will further complete baseline co gnitive, CAP, 
and everyday functional measures .  
 Those eligible who score 2 6
3 or better on the  MoCA will be enrolled in the study and referred to the study c o-
ordinator for randomization.   
 
Those  potentially  eligible w ho score between 20 to 25 on the M oCA  who were not referred by the MDC  or 
study physician will also comple te a clinic al evaluation v isit.  A cut -point of 20- 25 on the MoCA is indicative 
of probable MCI, while less than 20 is suggestive of dementia88.  
 
 
 
3 The MoCA cutpoint  was changed from 27 to 26 to use the more traditional and accepted value for impairment. Those who score be-
tween 20 to 25 will complete the clinical evaluation, rather than those who score 20 to 26.  
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 14 of 58  
 The purpose of the clinical evaluation is to determine if participants have MCI or dementia. The clinical evalu a-
tion visit will include subtests of the National Alzheimer’s Coordinating Center Uniform Data Set (NACC ) neu-
ropsychological battery and an exam by a study physician.  Subtests of the NACC battery will be used to dete r-
mine MCI status and exclude dementia.  The NACC battery subtests to be administered include the Clinical 
Dementia Rating Scale, the Multilingu al Naming Test,  the Benson Complex Figure Copy immediate and de-
layed subtests, the Craft Story 21 immediate and delayed recall subtests , Functional Assessment Scales , and 
Clinical Diagnosis Form, completed by a study physician who is a geriatric  psychiatri st. 
 
An excepti on to the above procedure will be for patients with MCI who were referred from the USF Health 
Memory Disorders Clinic (MDC) or a study physician who have already undergone clinical evaluation in the past 6 months.  Eligible and enrolled part icipants referr ed from the clinic with prior MCI diagnosis and evalua-
tion in the clinic completed within the past 6 months will be referred to study coordinator for random ization.  
 In replicate 1 and later replicates, w e plan to request lab resu lts from th e past year fro m those who score 20- 25 
on the MoCA.  The purpose is to rule out medical causes of cognitive decline that are treatable.   If copies of lab 
results are not obtained at the baseline visit, we will r equest that the participant comple te a releas e of medical 
records.  If we do not r eceive medical records by the clinical evaluation, and the study physician recommends  it, 
we may  draw blood and order lab tests that may include : 
• CBC  
• Metab olic panel  
• Thyroid Stimulating Hormone  (TSH)  
• B12 
• D 
• Folic Acid  
 Any results not within normal limits will be reviewed by a study physician  and communicated to the participant .   
 Those without any clinically significant abnormalities  that would likely interfere with their ability to benefit 
from interventio n
4 will continu e in the study.  
 
5.4   Describe consent procedures.  
 Written informed consent from participants will be obtained prior to in -person screening  at the first study visit.  
Research Assistants who have completed huma n subjects training and are app roved by the Institutional R eview 
Board will explain the study procedures, offer to read the consent form to the participant (and will do so, if de-sired), answer any questions, and obtain informed consent.  A flow chart that details the study visits and tim e-
line will be provided to the participant to help explain the study procedures.  Participants will be encou raged to 
take time to consider whether they wish to pa rticipate in the study.  The person obtaining consent will leave the 
room to provide the parti cipant time to read and consider the informed consent statement.  The parti cipant will 
be provided an opportunity to ask que stions prior to signing the consent (as well as throughout the study).  A 
copy of the consent form will be provided to the partici pant.  
 
 
4 We ad ded “and communicated to the participant”, and we added the clarification, “that would likely interfere with their ability to 
benefit from i ntervention”.   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 15 of 58  
  
All signe d consent forms will be kept in a locked filing cabinet separate from the data to ensure conf identiality.  
In the data quality control process, each consent form will be reviewed to ensure accurate completion and pr o-
tocol adherence.   
 
• Infor med consent wil l be an agreement between the investigators and each participant having the capac i-
ty to understand and make an informed decision.  Consent will be obtained prior to each potential parti c-
ipant’s particip ation in this study.  
 
• Each individual participating in this study will be made aware of the fact that his or her participation i n-
volves research and the intent of the research, the expected duration of their participation and a descri p-
tion of the proc edures that will be followed.   
 
• Each parti cipant will be made aware of the reasonably expected benefits he or she might r eceive, as well 
as any risks or potential discomfort that are involved.   
 
• Each participant will be made aware of alternative procedures that are available to him or her.   
 
• Each participant w ill be made aware that his or her records will remain confidential, but that the NIH, 
IRB, and OHRP have the right to inspect his or her re cords.   
 
• Each participant will be told that his or her participation in the clinical study  is volunta ry, without for ce 
or influence from the inve stigators or research staff.  
 
• Each participant will be given the name and method of contacting the appropriate person(s) to answer 
his or her questions about the research and in the unlikely event of r esearch -related i njury.  
 
5.5  Describe the procedure for obtaining intervention group assignment  
 
The s tudy coordinator with the statistician will randomize participants stratified by MCI status .  Participants 
with and without MCI will be randomized in a 1:1 r atio to either piano training or the active control condition of 
music listening  instruction .  To ensure balance throughout enrollment, randomization will be stratified by MCI 
status (present vs. absent) and conducted in varying blocks of participants as designed by Co -I Ji.  Dr. J i will 
generate the stratified permuted random blocks using R.   Dr. Ji will maintain the random seed and the computer codes and will send the randomization list to the clinical trial coordinator.  The treatment allocation will be  de-
noted as  A or B and rec orded on the randomiz ation form by the clinical trial coordinator.  The study coordinator 
will control access to the randomiz ation list and know whether A (B) stands for intervention (control).  Study 
investigators Edwards, Lister , and Andel  will remain blind to participant condition.  The testers will remain 
blind to participant condition. The trainers (including Co- I Bugos) and clinical trial coordinator will be aware of 
participants’ randomized condition.   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 16 of 58  
 5.6  STUDY INTERVENTIONS  
5.7  Interventions, Administra tion, and Duration  
 
There are two arms in this study including group piano training (intervention) and music listening instruction  
(active control) .  Both of these arms are described to participants as “music training”.  The detai led procedural 
protocol for both training arms can be found here:  P:\ CBCS \CSD CAL \Study 15 Music Training NIA\ Trainer 
Docs \Study 15 Music Training Procedure Protocol…. or upon request to the PI.   
 The content protocol for the piano training  arm can be fo und here P: \CBCS \CSD CAL \Study 15 Music Train-
ing NIA\ Trainer Docs \Piano training Manual_JB_Copyright_2018.docx or upon request to Co-I Bugos. 
 The content protocol for the music listening instruction  arm can be found here P: \CBCS \CSD CAL \Study 15 
Music Training NIA\T rainer Docs \Mus ic Listening PowerPoints.zip  or upon request to the PI .   
 
Participants will be scheduled by the trainers or study coordinator for in -lab intervention phase sessions in 
groups of up to 10 individuals by randomized condition.  We are limited to 10 persons per class due to the phys-ical space available for the music listening condition.  The piano and music listening labs are located on the USF campus and both can accommodate 10 participants in a group intervention session.  Scheduled  participan ts 
will be sent an appointment letter with directions and a map (by mail if visit is 8 or more days, by email if visit 
is within the next 7 days).  Participants will be reminded one to three days prior to the first intervention visit by 
telephone by a Research Assistant.    
 Both conditions will attend training two times a week for 10 weeks with the goal of completing a total of 20 sessions before post- testing.  Participants will be encouraged to complete training two times a week without 
missing two or more consecutive sessions.  Make up sessions will be held for each condition weekly, as need-ed
5.  The training phase can be extended up to a maximum of 15 weeks, if needed to complete 20 sessions .  Par-
ticipants will be encou raged to complete post- test regardless of intervent ion adherence.  We will code partici-
pants as completing training if 16 or more sessions are completed (16 to 20 sessions inclusive).  All training sessions must be completed within 15 weeks of training start date.  The Trainers wi ll confirm or reschedule t he 
participant to complete an immediate post- intervention assessment within 2 -60 days of their final in- lab inte r-
vention session (i.e., training completion date), or within 18 weeks of baseline if none of the the intervention phase was completed.  See further d etails below in Intervention Phase and Retention.  
5.7.1 Prohibited Interventions 
 Participation in cognitive interventions aimed toward enhancing or maintaining cognitive abilities will not be allowed.  This includes computerized cognitive tr aining or stimu lation exercises aimed at cou ntering cognitive 
decline.  Participants will be instructed not to participate in such activities during the entire study period.  Fo r-
mal music training, such as private music lessons or group music cl asses  or courses related t o music (as exam-
ple voice instruction or musical instrument instruction  or a music appreciation class ), outside of the assigned 
activities will not be allowed.  Individuals who participate in such interventions will be dropped from the study.  
 
 
5 The following sentence s were omitted:  Each of the conditions will have a textbook and will  be ass igned weekly  homework.  Partici-
pants will be asked to report the amount of time they spend outside of class completing such activities.  
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 17 of 58  
 Only data points prior to such participation will be included in analyses.  Participant will be deemed inelig ible 
at the time such an incident occurs.  
 
If the participant opts to undergo a surgical procedure th at requires general anesthesia or chemothe rapy or radi a-
tion, we will attempt to complete post- test prior to the surgery or procedure .  If the participant undergoes ge n-
eral anesthesia, chemotherapy, r adiation, experiences a head injury , stroke, or  heart attack, t he pa rticipant will 
be wi thdrawn from the study.  A ll available data points prior to the incident will be used in analyses.  The pa r-
ticipant will be deemed ineligible at the time of the incident.  
 
Participants will be provided a  post -test appointment letter that will include  instructions re garding these i tems 
when scheduled for post -test.  Also, the trainers will remind participants of these instru ctions on the first day of 
training.   
 
5.8  Adherence Assessment  
To address the study aims, we will use intent -to-treat analyses as detail ed in secti on 9.5 below.  We will report 
the percent of participants who were adherent to the assigned piano training  or music instruction  exercises.  Pa r-
ticipants will be considered adherent if they complete at least 80% of the assigned sessions (at least  16 of 20 
sessions ).  The Research Assistant Trainers will record dates that participants attended in -lab training.  Partic i-
pants will be allowed up to 15 weeks to complete the assigned exercises  between bas eline and post -test.   
 
Primary d ata analyses wil l be intent -to-treat.  Sen sitivity analyses will further examine effects of  piano training 
relative to music instruction  among those who were adherent  (i.e., who completed 16 or more hours)  in both 
condi tions.   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 18 of 58  
 6 CLINICAL AND LABORATORY EV ALUATIONS  
Schedul e of Evaluations 
Evaluatio n Measure 
type Telephone  
Screen ing 
(≤ 60 days)  Baseline  Clinical Evalu a-
tion 
(≤ 45  days)  Randomiz ation 
<3  
wks Intervention  
Up to 15 
wks Post-Test  
>2 days 
and <=60 
days  
Informed Consent R  X     
Inclusion/Exclusion Questionnaire I/E X X X   X 
Geriatric  Depression Scale (GDS)  I/E, C   X     
Demographic Data  C  X     
Montreal Cognitive As sessment (MoCA)  I/E, C   X     
Memory Screening History IV  X     
Hearing and vision screening  
Pure-tone Hearing Thresholds 
Speech Recognition Threshold 
Near Visual Acu ity 
 I/E, C 
 X 
   X 
Music Reading Assessment  I/E  X     
Central Auditory Processing  
Time Compressed Speech 65% Words- in-Noise Test  
Dichotic Digits Test Dichotic Sentence Identification test  
ATTR  O 
 X 
   X 
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 19 of 58  
  
Evaluation  Measure 
type Telephone  
Screen ing 
(≤ 60 days)  Baseline  Clinical Evalu a-
tion 
(≤ 45 days)  Randomiz ation 
<3  
wks Intervention  
Up to 15  
wks Post-Test  
>2 days 
and <=60 
days  
Cognitive Asses sment Battery  
Trail Ma king Test 
Digit Coding 
Verbal Fluency  
- BHR, Clothes/ Girls’ Names, Veget ables/ 
Musical Instruments ( baseline) 
- FAS, Animals/ Boys’ Names, Fruits/Furniture ( post- test) 
 O 
  X 
     X 
Everyday Functional A ssessment  
Timed IADL Test  
Test of Everyday Attention 
 O 
 X 
   X 
Questionnaires  
Health Questionnaire  
Medication Audit 
Health Changes  SC   
X X     
  
X 
Adverse Events  R  X X  X X 
Clinical Evaluation  
NACC assessments:  
-Clinical Dementia Rating Scale  
-Craft Story 21 Recall - Immediate and D e-
layed   
-Benson Complex Figure Copy and re call 
-Multilingual Naming Test 
-Functional Assessment Scale  
-Clinician Diagnosis form  SC 
  X 
   
 Keys to Staying Sharp 
  Version 2 
     08/08/2018 
Page 20 of 58  
  
Evaluation  Measure 
type Telephone  
Screen ing 
(≤ 60 days)  Baseline  Clinical Evalu a-
tion 
(≤ 45 days)  Randomiz ation 
<3  
wks Intervention  
Up to 15  
wks Post-Test  
>2 days 
and <=60 
days  
Lab Asses sments (upon IRB approval ) 
CBC  
Metab olic panel  
Thyroid Stimulating Hormone (TSH)  
B12 
D Folic Acid  
MRI (if funding acquired)  IV   X    
Randomization IV    X   
Advanced Measures of Music Audiation 
(AMMA) - Day 1 of Training  E     X  
Basic Piano Measure (BPM) OR  
Music Listening Me asure (MLM) - At d ays 1 
and 20 of t raining  E     X  
General Self -Efficacy and Music Perfo r-
mance Self -Efficacy ( At days 1 and 20 of 
training ) E 
    X  
Intervention sessions   C     X  
NICT Expectations Questionnaire (Between 
days 17 and 20 of training)  IV, C     X  
Tester blinding assessment IV      X 
C=covariate, E=exploratory, I/E=inclusion/exclusion, IV=internal validity, O=outcome, R=regulatory, SC=sample characterization   
 21 Keys to Staying Sharp 
  Version 2 
 
 
Page 21 of 58  
 6.1  Timing of Evaluations  
 
Prior to Randomization: The baseline visit should be scheduled within 60 days of the telephone screening inte r-
view.  Informed consent must be obtained first at the baseline study visit  prior to any data collection .  The GDS, 
MoC A, Music Reading Asses sment, as well as hearing and vision screenings must be c ompleted at baseline, 
prior to the clinical evaluation.  The central auditory processing measures, cognitive assessment battery, ever y-
day func tional assessments and health questionnaire should be completed at baseline, but missing items  can be 
administered  at the beginning of the clinical evaluation, if needed.  The clinical evalu ation should be completed 
within 45 days of the baseline visit  completion .  The NACC assessments will be completed at the clinical eval-
uation.  All the aforementioned measures  for the baseline and clinical eval uations should be completed prior to 
randomization and must be completed prior to the training content being administered.  It will be allowable to administer any of the aforementioned measures that are missing from the baseline or clinical visits after ra n-
domization, but administration will not be allowed once the participant has received any piano or music liste n-
ing trai ning.   
 Prior to Training Content:  Any biomarker assessments must be completed prior to training content (blooddraw, 
mri, etc.).  The g eneral and m usic self efficacy measures can be administered  at either baseline or  after rando m-
ization on day 1 of training, but must be administered prior to participants receiving any piano-  or music liste n-
ing- content traini ng.  If the basic piano or music listening measures are administered prior to randomization, 
the participant will be withdrawn from the trial and a protocol deviation will be noted.  The pre -training basic 
piano and music listening measures must be adminis tered after randomization and must be administered before 
training content is delivered.  If any of the aforementioned baseline, clinical, or pre -training  measures  are ad-
ministered after the training content began, a protocol deviation will be noted.  Such measures  will be coded as 
missing and will not be used in analyses.   
 Intervention Content:  The AMMA should be administered on day 1 of training, but it will be allowable to a d-
minister the AMMA within the first three training sessions.  The NICT questionnaire should be administered between days 17 and 20 of training, but can be administered at the beginning of the post -test visit if it not com-
pleted during the intervention phase.  The NICT questionnaire must be administered prior to the post -test a s-
sessm ents of CAP, cognition, or everyday function.  If the NICT que stionnaire is administered after the post-
test assessments of CAP, cognition, or everyday function a protocol devi ation will be noted.  In this instance the 
NICT questionnaire will be coded as m issing and will not be used in analyses.  The post -training basic piano 
measure and music listening measure must be co mpleted after all training content is delivered and prior to the 
post-test assessment visit.  The trainer should confirm with the study coordinator that all scheduled intervention 
sessions have been completed and the basic piano or music listening assessments are completed prior to the post-test visit.  The post -test visit can be rescheduled, if needed , but must occur within 18 weeks of bas eline if 
no intervention was  completed, or within 60 days of training completion date  (>= 16 sessions completed) .  Par-
ticipant post -tests will be conducted after the intervention phase for those who complete between 1 -15 sessio ns. 
6 
 
 
 
6 The sentence “Participant post -tests will be conducted after the intervention phase for those who complete betw een 1-15 sessions” 
and “ (>= 16 sessions completed) ” was added for clarification.  
 22 Keys to Staying Sharp 
  Version 2 
 
 
Page 22 of 58  
 Post-Test Content:  The  post -training general and music self -efficacy measures must be completed after all 
training content is delivered, but may be completed at the beginning of the post -test visit, if needed.  The post -
test assessments of CAP, cognition, and everyday functiona l measures cannot be completed until after a delay 
of at least 24 hours after the final intervention session (i.e., training com pletion date) .  The post -test assessm ents 
of CAP, cognition, and everyday function should ideally  take place within 2- 30 days  of the training completion 
date ( >= 16 sessions completed) .  The maximum window for post -test is that it must be completed within 60 
days of training completion, or within 18 weeks of baseline if no intervention phase was comple ted.  Participant 
post-tests w ill be conducted after the intervention phase for those who complete between 1- 15 sessions.6 
6.1.1 Pre-Randomization Evaluations  
 
Telephone screening is an initial interview conducted by Cognitive and Neurophysiology of Aging Lab staff to ascertain potential eligibility of the participants per the inclusion and exclusion criteria.  Eligibility will be eva l-
uated by the telephone screening .  If ineligible the reason will be documented.  Procedures for eligibi lity and 
enrollment are detailed above.  Those potentially eligible will be scheduled to complete a baseline visit within 30 days.  If the telephone screening questionnaire has not been completed within 60 days  of scheduling bas e-
line, it should be repeated .   
 A subject ID number  will be assigned on the participants visit control sheet ( VCS ) by the tester at their first 
study vi sit.  Informed consent will be obtained at the beginning of the first -in person visit, the baseline visit.  
Participants will be provided a flow chart that explains all of the study visits, duration of the visits, and the ti m-
ing of the visits during the consent process.  At the baseline visit, participants will complete the MoCA, GDS, hearing, and vision screenings , and MRA  to determine eligibility .  Those n ot eligible due to MoCA, GDS, hea r-
ing or vision scores will be referred to the appropriate professionals for treatment.  Additionally, participants for whom outer or middle ear pathology is indicated through otoscopic examination will be referred to an otolary n-
gologist or other professional and will not continue in the study.  Those participants who are eligible will be e n-
rolled in the study and will further complete thorough assessments of CAP , cognition, and everyday function.  
A questionnaire assessing  health  will be completed.  Research Assistant Testers who will remain blind to partic-
ipant condition will complete these assessments.  Participants will be referred to the s tudy coordinator  for ra n-
domiz ation.   
 If the participant meets eligibility criteria , was not referred from the MDC  or a study physician, but scores be-
tween 20 -25 on the MoCA, a  clinical evaluation will be performed by a study physician to a scertain diagnosis 
of mild cognitive impairment and ensure that clinical inclusion criteria are met  and no exclusion criteria are e v-
ident.  Reasons for ineligibility will be documented.  This clinical evaluation should be completed as soon as 
possible following the baseline visit  and should take place within 45 days after  the baseline visit.  
 
6.1.2 Interventi on Phase  
 Within three weeks of baseline  or clinical evaluation  phase completion  for each replicate, the  Clinical Research 
Coordinator and/or  Research Assistant Trainers will randomize enrolled participants in co llaboration with Dr. Ji  
and schedule the ir first intervention visit.  Participants will complete rando mized exercises in groups of up to 10 
individuals at in -lab sessions that are 90 minutes  in duration, occur ring two times a week over the subsequent 
~3 months .  The goal will be for 95% of the training sessions to be conducted in groups of 3- 10 persons. Cla s-
 23 Keys to Staying Sharp 
  Version 2 
 
 
Page 23 of 58  
 ses will be arranged such that those with MCI primarily train together within randomized condition.  The inte r-
vention phase will continue until 20 total sessions are completed or 15 weeks have pas sed.  The t rainers will 
confirm or re schedule the participant to co mplete an immediate post- intervention assessment .  The trainers will 
make certain that all scheduled intervention sessions are completed prior to the post -test visit and that no train-
ing se ssions are scheduled after the post -test visit. Fidelity will be assured as described below (See Quality A s-
surance below ). 
 
At the first training sessions the trainers will administer the A dvanced Measure of Music Audiation (AMMA) , 
General Self -Efficacy Fo rm, and the Music Performance Self -Efficacy form .  Those in the music listening con-
trol group will complete the music listening measure while those in piano training will complete the basic piano measure.  The training protocols detail all of the procedure s and content  protocols detail  the training arms.  
Please see: P:\ CBCS \CSD CAL \Study 15 Music Training NIA \Trainer Docs \Study 15 Music Training proc e-
dure protocol .   
 Between sessions 17 and 20, the t rainers will administer the The Cognitive Training Expec tations  NICT  ques-
tionnaire to examine participants’ attitudes and expectations about the  potential effects of the  intervention  com-
pleted .  If a participant does not complete this questionnaire during the intervention phase, it may be completed 
at the begin ning of the post -test visit.   
 At the participants’ last training visit, the  self efficacy measures will again be completed, and the trainer will 
verify that participants learned basic musical concepts and skills introduced in the program with at least 70 % 
accuracy .  If participants score less than 70% correct on the Basic Piano Measure (for piano training condition) 
or Music Listening Measure (for music listening condition), as applicable to randomized condition, at their last scheduled training session a nd if they have  completed  less than 20 sessions, then the trainer will an attempt to 
schedule additional make -up training sessions to complete up to 20 se ssions.  The trainers will make certain that 
the post -test visit is rescheduled, if needed.  All train ing sessions must be completed within 15 weeks of training 
start date.  
 
6.1.3 Post-Test  
 At the  post -test visits , cognition- ,CAP - and everyday function outcome  measures  will be re -administered  by 
blinded Research Assistant Testers .  Participants will complete the  CAP, cognition, and everyday function 
measures administered at baseline.  Alternative forms will be used, as available.  The Tester will complete a form indicating whether or not they know the randomized condition of the participant to assess success of  blind-
ing and will confirm continued eligibility .  A questionnaire will be administered to check for adverse events 
during the course of the study.  Participants will be encouraged to complete post -test regardless of adherence.  
We will attempt to complete  post test for up to 60 days after the training completion date ( >=16 sessions com-
pleted) or 18 weeks post baseline if intervention was not attempted  or completed .  Participant post -tests will be 
conducted after the intervention phase for those who complet e between 1 -15 sessions.
6 
 
6.2  Overall Project Timeline  
A detailed and up- to-date field schedule will be maintained to indicate the dates of each phase of the study for 
each of the pilot and five to six replicates.  This sched ule can be located at P: \CBCS \CSD CAL \Study 15 Music 
 24 Keys to Staying Sharp 
  Version 2 
 
 
Page 24 of 58  
 Training NIA.  Study data will be collected across a pilot and five to six repl icates.  The field schedule indicates 
the timeline for each phase of data collection during each repl icate.  Each replicate will last between 180 to 210 
days.  There should be at least two weeks between completion of the baseline/clinical phase and beginning of 
training phase to allow for randomization, scheduling, and coordination of intervention phase.  The training phase wil l be 10- 15 weeks in dur ation.  We will attempt to complete post test for up to 60 days after training 
completion date (or 18 weeks post baseline if intervention was not com pleted).   
 
6.3  Intervention Discontinuation Evalu ations Retention  
 A CONSORT chart wil l be completed at the end of the trial.  Participant status (e.g., screened,  enrolled, refused, 
ineligible) will be recorded at each assessment.  Reasons for ineligibility will be doc umented.   
 We will employ an  inten t-to-treat design  as detailed in secti on 9.5 below .  Participants  who discontinue inte r-
vention will be encouraged to complete study visits and we will make every eff ort to follow and evaluate all 
enrolled  partic ipants.  
 
6.3.1 Retention  
 We will employ several methods to encourage participation.  In  the consent process, we will stress that enro l-
ling in the study involves a commitment to complete up to 23 in pe rson visits: 3 testing visits and up to 20, 90-
minute , in-lab training visits.   
 We find that asking participants to schedule their next appoi ntment visit at the end of each study visit encour-
ages continued participation.  At each testing visit, we will provide a copy of the study flow chart with a p-
pointment times completed to remind them of the study visits and their progress.   
 Participants w ill be reminded the day before all scheduled testing visits by phone of their appointment time.  
They will be reminded 1- 3 days prior to their first intervention (i.e., training)  session.   
 We will indicate for each participant the best manner (e.g., emai l, phone, cell) and times to contact them to f a-
cilitate communication.  We will also ascertain information for a secondary contact person for each study pa r-
ticipant to facilitate follow -up.  Such secondary contact individuals will be a pproached if we lose contact with 
the enrolled study participant with no response to phone calls or a letter after repeated attempts over a 90- day 
period.    At the first in -lab intervention visit, pa rticipants will complete a statement indicating their commitment to co m-
plete  training sessions two times a week  in order to complete 20 sessions.  The statement  will be signed by the 
participant  and a witness.  For any planned absences, an alternative make -up session will be scheduled.  Typi-
cally in -lab intervention sessions are of fered at regular times on Tuesday, Thursday or Monday, Wednesday, 
with make -up sessions scheduled on Friday.  However, every ef fort will be made to accomodate participants’ 
schedules  (e.g., offering Saturday training sessions) .  The trai ners will provide a  schedule of in -lab training at 
the first intervention study visit.  In week 8 of training, the trainers will confirm post -test visits for  each partici-
pant.  At this time, participants will again each be provided with a flow chart of the study visits with their sp e-
 25 Keys to Staying Sharp 
  Version 2 
 
 
Page 25 of 58  
 cific study visit dates indica ted.  For any participant who could not be confirmed or rescheduled, the trainer will 
refer this person to the study coordinator who will assist.   
 Participants who miss an in -lab training session unexpectedly (i.e.,  without having a make -up session sche d-
uled) will be contacted by the Research Assistant Trainer or lab  staff within 3 days of the missed session.  Pa r-
ticipants will be requested to schedule a make -up in- lab training se ssion as soon as possible.  Participa nts will 
be reminded that their goal is to complete 20 sessions before post -test I visit.  We will further encourage the 
participant to return for their post -test assessment visit regardless of training adherence.  If we do not succes s-
fully make contact wi th the participant  within the first three days , we will conti nue to attempt to contact them 2 -
3 times per week for three weeks.  If we are still unable to reach the participants, we will send a letter  requesting 
a reply .  Secondary contact individuals will  be approached if we lose contact with the enrolled study participant 
with no response to phone calls or a letter after repeated attempts over a 90 -day period.   
 If participants are finding it difficult to attend the in -lab sessions, we will allow  up to t hree sessions of training 
to be completed each week  (1 session per 24 hours) until the intervention phase has ended or 15 weeks have 
passed since training began .  
 
6.3.2 Documentation of MCI or dementia  
For participants that score between 20- 25 on the MoCA and w ho have not been referred by a study physician, 
the clinical evaluation visit will be completed.   The clinical evaluation visit will be completed after baseline and 
before randomization.  It should take place within 45 days of baseline, if possible.  Parti cipants will be reques t-
ed to bring an informant (a relative or spouse or close friend who has regular contact with them who could r e-
port on their eve ryday activities ).  The informant will provide assent to participate in the study.  We will allow 
informant s to be interviewed by telephone, if unable to attend in- person.  An evaluation will be performed by a 
qualified clinician  to determine/confirm a  diagnosis of MCI or dementia .  After the participants complete 
NACC assessments, study physicians will evaluat e the par ticipant at the end of the clinical evaluation visit.  The 
study physician will complete the Clinical Dia gnosis Form and determine eligibility.  
6.3.3 Concomitant Treatments  
 Participants will be allowed to undergo their usual treatment for health condi tions.   
6.3.4 Study Intervention Modifications  
 If at interim analyses, an effect size of d= 0.25 or greater  reflecting improvements from piano training relative 
to controls  is not observed on at least one of the cognitive outcomes measures (verbal fluency, Tra ils, Digit 
Coding) relative to controls , we will randomize the remaining participants to 25 sessions (i.e., 37.5 hours)  in-
stead of  20 sessions ( i.e., 30 hours ) of training.  
6.3.5 Measures  
• Eligibility will be assessed in -person by measuring near visual acuity, hearing, cognitive status  (MoCA) , 
Music Reading Assessment (MRA),  and depressive symptoms  (GDS) .  These variables and 
demographic information may also be considered as covariates  in analyses .  
 26 Keys to Staying Sharp 
  Version 2 
 
 
Page 26 of 58  
 o Near Visual Acuity will be measured at 40 cm using standard pro cedures with a Sloan letter 
chart, and the log minimum visual angle resolvable will be quantified 89.   
o Hearing thresholds will be assessed using standard procedures ( American Speech -Language-
Hearing Association. (2005). Guidelines for manual pure-tone threshold audiometry  [Guidelines].  
Available from www.asha.org/policy .) and calibrated equipment from the USF Hearing Clinic.  
Otoscopic exam will be performed prior to inserting ear phones for pure tone testing. Pure tone 
air conduction thresholds in dB will be measured at 250, 500, 1000, 2000, 4000, 6000, and 8000 
Hz in each ear.  At post- test, these thresholds will be re -measured only if the participant reports a 
noticeable change in hearing since baseline testing (per Health Changes Checklist ).  Prescription  
for, use of (e.g., hours per day), and type of hearing aids will be recorded  for each  ear. 
o Speech Recognition Threshold (SRT) will be assessed using standard procedures ( American 
Speech -Language-Hearing Association. (1988). Determining thr eshold level for speech  [Guidelines]. 
Available from www.asha.org/policy .) and calibrated equipment from the USF Hearing Clinic.  
An SRT will be measured for each ear.  At post- test, these thresholds will be verif ied and presen-
tation levels of all auditory tests will be adjusted if the SRT in either ear varies by more than +/ - 
5 dB.  
o The Montreal Cognitive Assessment (MoCA) will be used to examine participants’ cognitive st a-
tus 88.  This assessment has go od internal consistency, Cronbach’s α=.83, and test -retest reliabi l-
ity, r =.92 88.   
o The Geriatric Depression Scale (GDS) will be used to screen depressive symptoms.  The GDS 
has 92% sensitivity and 89% specificity to detect depression and has good test- retest reliability 
of r=.75-.81 90, 91.   
o Music Reading Assessment (M RA) 92 consists of a 40- item measure of basic music reading abi l-
ity with 20 treble clef items and 20 bass clef items.  
 
• Outcomes  include binaural central auditory processing ( CAP ) measures of : Time Compressed Speech 
65%, Words- in-Noise, Dichotic Digits Test, Dichotic Sentence Identification, and Adaptive Tests of 
Temporal Resolution.  If any participant expresses discomfort with the presentation level, it will be a d-
justed to a comfortable level.  The presentation level is recorded for each measure. 
 
o Time Compressed Speech Test (TCS).   The TCS test assesses both auditory temporal pro-
cessing and degraded speech understanding.  It is a word recognition task in which the timing 
feature of the speech is digitally manipulated to resemble rapid speech  93, 94.  TCS performance 
worsens with age 95.  Auditec Recordings Northwestern University Auditory Test Number 6 re c-
orded sentences (e.g., “Say the word jug”) are available at both 45% and 65% compression (65% is faster).  The listener must repeat the last word (test item), after the introductory sentence “Say the word”, which preceeds every test item.  The talker is female and approximately 4 sec of s i-
lence separate the stimuli.  Participants are asked to repeat 50 words delivered through insert earphones at a level of 50 dB SL (re: SRT), and percent correct is calculated.  Normative data on time compressed speech performance in adults have been descr ibed elsewhere 
96.  For the pre sent 
study, only the 65% condition will be used. 
o Words- in-Noise Test (WIN).   The WIN is a test of degraded speech understanding or speech 
understanding in noise.  It was developed as an  instrument that quantifies the ability of  listeners 
to understand speech in background multi- talker babble 97.  The stimuli are the Northwestern 
University Auditory Test Number 6 monosyllabic words with a static preceding sentence (e.g., “Say the word road”) and a background of multi- talker babble.   The talker is female and appro x-
 27 Keys to Staying Sharp 
  Version 2 
 
 
Page 27 of 58  
 imately 3 seconds separate each sentence.  T wo 35 -word  lists are used; 5  words are presented at  
each of 7 signal -to-noise ratios ( SNRs ).  The SNRs are presented in a decending manner, from 
24 to 0 in 4- dB increments.   The babble is maintained at a fixed level.  Listeners must repeat the 
last word of the sentence, ignoring the babble.  The WIN uses a modified  method of constants to 
establish the  SNR at which 50% correct performance is  achieved on the materials.  The 50% 
point is computed with the Spearman -Kärber  equation 98, 99 [50% = 26 – (#co rrect)(0.8); “0.8” is 
the attenuation step size (4 dB) divided by the number of words per step (5)].  The WIN has been 
established as a reliable measure (intra- class correlation coefficient = 0.88) 100, 101. 
o Dichotic Digits Test (DDT).  The DDT is a test of binaural processing that uses a closed set of stimuli (numbers), thus having a relatively low linguistic load.  The DDT consists of numbers between one and nine, excluding the two- syllable number seven ( r=.79-.97)
102.  Two numbers 
are presented to the right ear while two numbers are presented simultaneously to the left ear , for 
a total of four numbers.  The talker is male.  Approximately four seconds of silence separate each set of four numbers, and approximately one second separates the individual pairs within a set of four.  The participants are instructed to repeat all four numbers that were presented to them, in any order.  Twenty -five sets of four numbers each are presented, for a total of 100 stimuli.  Th e 
test is scored as a percent correct out of the 100 numbers presented.   
o Dichotic Sentence Identification (DSI).  The DSI test is used to assess binaural speech unde r-
standing in competition and also falls into the broad category of degraded speech understanding.  The DSI stimuli are identical to those of the Synthetic Speech Identification Test (SSI)  
103, rec-
orded grammatically correct yet meaningless sentences (e.g., “Small boat with picture has be-come”).  Unlike the SSI, for the DSI a competing sentence is delivered to the contralateral ear.  The DSI is presented at a level of 50 dB SL (re: SRT) via insert earphones; the talker is male and approximately 8 sec of silence separate the sentences.   Participants are required to select both 
sentences heard from a closed set list of 6 sentences, and results are scored as percent correct.  Test-retest reliability of the DSI is high in older adults, r  = .79 - .97.  Deficits in DSI perfo r-
mance may be predictive of cognitive decline 
104. 
o Adaptive Tests of Tem poral Resolution (ATTR).  The ATTR105 is a copyrighted and freely 
downloadable test of auditory temporal processing.  Details regarding the ATTR have been pub-lished previously
105-107.  Briefly, the ATTR is  used to measure gap detection thresholds using a 
three- interval, two -alternative forced -choice adaptive procedure targeting 70.7% correct gap d e-
tection.   The stimuli used to define the silent gaps are ¼ octave narrow bands of noise (NBN) 
centered on either 1 kHz or 2 kHz.  Before the silent gap, the NBN is 300 ms in duration.  After 
the silent gap, the NBN varies randomly in duration between 250 and 350 ms.  The participant is 
presented with three intervals of sound, a reference interval, a standard interval identical to the 
reference interval, and a target interval.  In the reference and standard intervals, two NBNs sepa-
rated by a 1 -ms gap are presented.  In the target interval, two NBNs separated by a gap of adap-
tively varying duration are presented.  The reference interval is presented first and the standard 
and target intervals are presented in random order, following the reference interval.  The partic i-
pant’s  goal is to select the target interval from among the standard and target intervals.  The pa r-
ticipant is not allowed to select the reference interval.  Two subtests of the ATTR were used in 
the present study, the within-channel subtest for which NBNs before and after the gap are both 
centered on 2 kHz and the across-channel subtest for which the NBN before the gap is centered 
on 2 kHz and the NBN after the gap is centered on 1 kHz.  The ATTR was presented at a high, 
comfortable level, self -selected by each participant as described by Cox108.  Reliability for the 
ATTR has been established with intraclass r =.58-.87105. 
 28 Keys to Staying Sharp 
  Version 2 
 
 
Page 28 of 58  
 • Outcomes  also include c ognitive measures:   Verbal Fluency Test (phonemic fluency, category fluency, 
and category switching), Trail Ma king Test, and  Digit Coding  
o Verbal Fluency109.  Executive function will be assessed with phonemic , category, and category 
switching  verbal fluency tasks.  Phonemic fluency consists of three, one -minute trials during 
which the examinee names as many words as can be thought of that begin with a given letter, e x-
cluding proper nouns, numbers, and the same word with a different suffix will also be assessed 
(test-retest reliability=.88)110.  Categ ory fluency is designed to mea sure the speed and flexibility 
of verbal thought processes ( r=0.82; sensitivity=.88; specificity=.96)109, 111.  A switching condi-
tion is included that requires participants to alternate between sets (e.g. naming fruits and fur ni-
ture)  (r=0.51 ).  Different versions of this measure will be administered at baseline and post -test.  
The BHR, Clothes/Girls’ Names, and Vegetables/Musical Instruments will be administered at 
baseline while the FAS, Animals/Boys’ Names, and Fruits/Furnitu re version will be admini s-
tered at post -test. The recorded score is the number of correct items for each task.  
o Trail Making Test Part A.   Speed of processing is evaluated using the Trail Making Test Part 
A.  This test ( r=.53- .64), requires participants to draw a line connecting a series of numbers in 
sequential order (1- 2-3, etc)112.  The recorded score is the time required to complete the task113. 
o Trail Making Test Part B.   Executive function is evaluated using the Trail Making Test  Part B, 
which is a r eliable measure ( r=.54-.62) that requires participants to draw a line connecting a s e-
ries of number and letters in alternating, sequential order (1 -A-2-B, etc) (Strauss et al., 2006).  
The recorded score is the time required to complete the task113, 114. 
o Digit Symbol Coding .  Cognitive speed of processing is evaluated using Digit Symbol Coding 
109.  This test consists of 135 blank squares  that are pa ired with a  number from one to nine.  A 
reference key links each number to a different geometric figure .  Using the ref erence key, parti c-
ipants have 120 seconds to copy the geometric figure assigned to the number into the blank box-
es.  Scaled scores are obtained by subtracting the number of errors from the number of correct 
responses.  Lower scores indicate better performance.  Psychometric properties are reported in 
the manual.  
 
• Outcomes of e veryday function include the Timed IADL and TEA tests  
o Timed IADL  involves timed performance of five tasks encountered in daily life.  The pr eviously 
validated tasks115 utilize real -world stimuli and represent five IADL domains, including comm u-
nicati on (finding a telephone number in a phone book), finance (making change), cooking (rea d-
ing the first three ingredients on a can of food), shopping (finding two items on a shelf of pac k-
aged foods) and medication management (reading the directions on a medic ine bottle label).  
Scores are generated by combining the completion time and error code for each task per standard 
procedure.  Task scores are combined into a single composite by taking the average of z  scores 
computed for each of the five tasks after err or correction.   Test -retest reliability of the Timed 
IADL is r  = .85 115. 
o The Test of Everyday Attention (TEA)116, 117 consists of eight  sub- tests designed to meas ure 
different types of attention .  The subtests are designed to mimic everyday tasks that encompass 
both visual and auditory domains.  The test -retest reliability of v ersions A to B range from .59 -
.86116.  Four of the eight subtests will be administered in this study and include : 
 Visual Elevator.  Participants count up and down floors as they follow a serie s of vi sual-
ly presented doors and arrows.  An accuracy (how many final floor numbers the partici-pant gets correct out of 10) and timing scores (total time taken for the correct items) are 
 29 Keys to Staying Sharp 
  Version 2 
 
 
Page 29 of 58  
 obtained.  The reported score is the total time taken divided by the number of switches 
for the correct items  and the scaled score.  This subtest measures atte ntional switching117.  
 Elevator Counting wth Reversal.   As with the Visual Elevator subtest, participants 
count up and down as they follow a series of visually presented doors.  I n this subtest 
however, the tones are at a fixed speed.   The recorded  score is the number of cor rect an-
swers out of 10 and the scaled score.  This subt est measures auditory -verbal working 
memory117.  
 Telephone Search.   Participants search  for symbols while searching for entries on a rep-
licated page of a telephone directory.  The recorded  score is the time per target score  
(number of correctly detected symbols divided by the time taken to identify the correctly detected symbols) and the scaled score.  This subtest measures selective attention
117.  
 Telephone Search While Counting .  Participants search the telephone directory while 
counting strings of tones simultaneously.  The recorded score is obtained by the co m-
bined performance on the Telephone Search and Telephone Search While Counting give s 
a measure of divided attention, as well as the scaled score.   This subtest measures sus-
tained attention117.  
 Exploratory measures   Exploratory mesures include a measure of music aptitude and two self- efficacy measures.   
 Advanced Measures of Music Audiation (AMMA) consists of 30 paired piano melodies that is used to evaluate music aptitude
118.  Test - retest eliability for music majors is  r=.89 and non- music majors, r =.83118.   
 
The General Self -Efficacy119 is comprised of 23 positive and negative items on a 14-point Likert scale ranging 
from strongly disagree (1) to strongly agree (14).  Internal reliability is established (α=.86-.71).  Items are de-
signed to reflect elements of effort, initiation, and persistence as described in Bandura’s social cognitive theory.  
 An adapted version of t he Music Performance Self -Efficacy Measure
120 will be used.  This questionnaire 
(α=.97)  consists of 24 items to which participants respond by selecting a number (0–100) to reflect strength of 
agreement to a specific statement regarding musical beliefs (0 = strongly disagree … 100 = strongly agree).  
The items included are based on  Bandura’s sociocognitive theory and assess domains : mastery experiences 
(eight items), vicarious experiences (five items), verbal/social persu asion (six items), and physiological state 
(five items).  An example of an item from this measure is, “I have had positive experiences performing music in 
the past.” This measure has been used in studies with older adults121.  The adaptation from the original version 
includes a change in the order of the questions and changes in the wording of 7 questions.  More specifically, 
the question, “I have improved my music performance skills by watching professional musicians, who are sim i-
lar to me in some way, perform well”, was changed to “I have improved my music performance skills by watch-
ing professional musicians perform well”.  The question, “My friends think I am a good performer on my pr i-
mary instrumen t”, was changed to “My friends think I am a good performer on my piano”.  The question, “I 
have had positive experiences performing in large ensembles” was changed to “I have had positive experiences 
performing in large ensembles (more than 11 performers)”.  The question, “I have improved my music perfor-
mance skills by watching other students, who are similar to me in some way, perform well” was changed to “I 
have improved my music performance skills by watching someone I know perform well (parent, brother, sister, 
church member, etc,)”.  The question “I have had positive experiences performing solo, or, in a small ensemble” 
was changed to “I have had positive experiences performing music solo”.  The question, “I have had positive 
 30 Keys to Staying Sharp 
  Version 2 
 
 
Page 30 of 58  
 experiences performing musi c in large ensembles” was changed to “ I have had positive experiences pefo r-
maing music in a small ensemble (2 -10 performers)”.   Lastly, the question “Performing with my instrument 
makes me feel good” was changed to “Performing on piano makes me feel good”.  
6.3.6 Questionnaires 
 
A health questionnaire will be administered at baseline to characterize the sample.  Participants are asked whether a doctor or nurse every told them that they any of the following conditions: arthritis, asthma and/or other breathing problems, cancer (other than skin cancer), chronic skin problems, diabetes, heart disease, heart problems (other than heart disease), high cholesterol, hypertention or high blood pressure, mood problems or anxiety, multiple sclerosis, osteoporosis, parkinson’s disease, stroke, TIA/mini-stroke within last 18 months, mild cognitive impairment or memory impairment, neuropathy, or any other significant illness.   Participants’ expectations  about the effects of intervention/control exercises on post- test outcomes  will be e x-
amined as a potential covariate.  During the last week of the inter vention stage, the Trainers will administer a 
modified version of the The Co gnitive Training Expectations questionnaire to examine participants’ attitudes 
and expectations about the effects of the intervention received  on cognition and everyday function
122.  The 
NICT questionnaire was modified to refer to “music training” or “piano training”, and  the “memory” and “rea-
soning” questions were omitted sinc e we are not assessin g these abilities .  The quesionnaire explains that cogni-
tive function refers to abilities such as attention, memory, visual perception, information processing, and re a-
soning; and that cognitive training refers to activities that aim to  improve cognitive functions by training within 
a specific timeframe (i.e., several weeks or months).  The questionnaire then asks participants to rate what e f-
fects they expect the intervention exercises to have including whether the exercises will result in improved gen-eral cognitive function, memory, concentration, distractability, reasoning, multi-tasking, and everday perfo r-
mance.  Ratings are on a 7 -point Likert scale ranging from completely unsuccessful (1), to no expectations (4), 
to completely succes sful (7).  Participants also rate the degree to which the intervention was engaging, enjoya-
ble, and challenging on a 7-point scale ranging from very strongly agree (7), to neither agree or disagree (4), to very strongly disagree (1).  Finally, participants rate whether or not they were satisfied with the program rang-ing from extremely satisfied (7), to neither satisfied or dissatisfied (4), to extremely dis satisfied (7)  and indicate 
whether they felt that they had “trained their brain” (yes/no).  This questionnaire has been successfully impl e-
mented in others’ and our prior cognitive intervention studies.  
 At the baseline visit, a list of prescription  medications that the participants’  are taking will be recorded.  For 
those who score 20-25 on the MoCA who wi ll be completing a clinical evaluation, the medication list will be 
provided for the study physician to review.  At the clinical eva lution visit, the tester will review the list of medi-
cations with the participant and document any changes prior to the part icipant seeing the study physician.  The 
study physician uses this information in the clinical diagnosis or exclusion of MCI.   A questionnaire will be administered at post- test to assess if any health -changes were experienced by the parti c-
ipants during the trial that could affect cognitive or functional performance.  Participants are asked if they expe-rienced any significant changes in health conditions such as head injury, chemotherapy or radiation treatment, heart attack or myocardial infarction, changes in vision or hearing, or underwent general anesthesia.  They are 
also asked if they had any new diagnoses of stroke, mini-stroke, TIA, heart disease or congestive heart failure, Parkinson’s disease, m ild cognitive i mairment or memory impairment, Alzheimer ’s disease, and Multiple Scle-
rosis.   
 31 Keys to Staying Sharp 
  Version 2 
 
 
Page 31 of 58  
 7 MANAGEMENT OF ADVERSE EVENT S 
We will track safety throughout the trial.  Participants will be queried as to whether or not they experienced any 
discomfort at the end of each study visit.  See Reporting of Adverse Event s below for further details. Data and 
safety monitoring will focus on participant recrui tment, data quality, and safety (confidentiality, minimization 
of risks, and surveillance for adverse events).  The study team will meet weekly to discuss the progress of the trial.  Details on adverse event monitoring and reporting are provided below .   
 An adverse event (AE) is defined as any unfavorable and unintended diagnosis, symptom, sign, syn drome or 
disease which either occurs during the study, having been a bsent at baseline, or if present at baseline, appears to 
worsen.  Adverse events are to be recorded regardless of their relationship to the study interve ntion.   
 Participants may experience fatigue or frustration  from completing the intervention exercises.  P rolonged sitting 
activity can result in muscle/joint soreness (e.g., wrist, elbow, fingers, hip flexors, neck, back , buttock), eye 
strain, muscle cramping or stiffness, or hea daches.  Any of these symptoms that increase in frequency and last 
more than 24 hours after participating in intervention exercises will be considered an adverse event.  The parti c-
ipant will be advised to seek treatment and not be continued until a physician clears such activity.  Serious a d-
verse effects from pri or research of the inte rventions have not been reported. 
 A serious adverse event (SAE) is generally defined as any untoward medical occur rence that results in death, is 
life threatening, requires inpatient hospitalization or prolongation of existing hospitaliz ation, results in persistent 
or significant disabi lity/incapacity .  
 
8 CRITERIA FOR  PARTICIPANT  DISCONTINUATION  
 Participants who undergo  any surgical procedures requiring anesthesia, chemotherapy, or radiation during the 
study period will be excluded.  Parti cipants who exper ience a stroke, TIA, or head injury during the study per i-
od will be excluded.  Participants who complete any other cognitive intervention not a ssigned to them during 
the course of the study will be excluded.  In these situations, only data points collected prior to the event will be 
used in analyses.  If plans to undergo such events are  known, and 80% of assigned intervention sessions have 
been offered , an attempt to com plete post -test prior to the event  will be made.   
9 STATISTICAL CONSIDERATIONS 
9.1 General De sign Issues  
 We will employ a  randomized clinical trial design to accomplish the study objectives.  Randomization will be 
stratified based on MCI status.  Regardless of randomization  or adherence, e ach eligible and enrolled pa rticipant 
will be encouraged t o complete post -test.  Participants may be followed longer with positive results and addi-
tional funding.   
9.2  Primary Objectives  
The primary and secondary outcome measures are detailed above.   
 32 Keys to Staying Sharp 
  Version 2 
 
 
Page 32 of 58  
 9.2.1 Primary outcomes  
• To examine the efficacy of piano training to i mprove CAP, cognition, and everyday function among 
older adults.  We will assess the effects of piano training as compared to music list ening instruction  on 
CAP, cognition, and everyday function.  
 
CAP includes Time C ompressed Speech, Words -in-Noise, Dichotic Digits Test, Dic hotic Sentence Identific a-
tion and Adaptive Tests of Temporal Resolution.  All are parametric tests of perception.    Cognition includes Verbal Fluency (phonemic, category, and switching), Digit Coding, and Trail Making test.  All are pa rametric tests of cognitive function.   
 Everyday function includes the Timed IADL test and Test of Everyday Attention both parame tric measures.  
Both measures will be examined individually.    Principal Component Analyses (PCA) wil l be performed with CAP , cognitive and functional  measures to form 
composites of outcomes  for use in analyses to reduce the number of comparisons. 
 Hypotheses: The piano training group will outperform the music listening instruction group on measures of CAP, cognition, and everyday function immediately post -intervention.  
Secondary Objectives  
 The secondary objectives are:  
 
• To examine the moderating effects of MCI on piano training efficacy.  Moderating effects of MCI status will determine if piano training is effective for older adults with and/or without MCI.  We do not have a directional hypothesis for this objective.  
 
• To explore mediators of intervention effects.  
 Hypothesis : Grounded in theory
8 and prior research9-11, we hypothesize that piano trai ning will improve 
CAP and cognitive performance, leading to functional improvements.  We expect that enhanced CAP will mediate cognitive gains.  We further hypothesize that cognitive gains will mediate functional im-provements.   
 
9.3  Sample Size  
 We expect up to 20% attrition after the initial in -person visit across the time period in which cognitive interve n-
tion study protocols will be administered.  Our goal is to complete in -person screening visits for up to 450 pa r-
ticipants in order to have up to 360 participants complete the study.  We can tolerate higher rates of attrition.  We require  a minimum of 198 eligible participants with at least  99 individuals randomized to each condi tion 
(piano training, controls)  to have adequate statistical power .  With stratified randomization, this will result in at 
least  48 persons per MCI/no MCI subgroup.   
 
 33 Keys to Staying Sharp 
  Version 2 
 
 
Page 33 of 58  
 Statistical power analysis using G*Power123 in consideration of our pilot data effect sizes a s well as attrition  
was conducted to estimate power .  We will control type I error at .05 to achieve at least 80% statistical power.   
 
To power Specific Aim 1: To examine the efficacy of piano training to improve CAP, cognition, and eve-
ryday function amon g older adults , a final n of 198 participants (n= 99 per randomized condition) will achieve 
95% power to detect a significant group x time interaction across baseline to immediate post -test, with an alpha 
of .05.  This assumes a small effect size ( f ) of 0 .10124 (Cohen’s f  effect sizes are 0.10 - small, 0.25-  medium: f  is 
roughly equivalent to ½ of d when comparing two groups)124.  
 
To power Specific Aim 2: To examine the moderating effects of MCI on intervention efficacy, a final n of 
168 will have . 95 power at alpha .05 to detect medium effects ( f=.10) for significant group x time x moderator  
three way interactions. 
 
9.4  Data Monitoring  
To achieve robust and unbiased results, data will undergo a rigorous quality control process to ensure 
consistency in scoring, coding and accuracy of data entry.  Additionally, 20% of all data folders will undergo a random audit every replicate.  Also see D ata Management  procedures  and Quality Assurance  detailed below.   
 
9.5 Interim Data Analyses 
Interim analyses will be conducted in June of 2019, after the pilot, first , and second replicates are completed.  
We expect  that 140 participants will have completed post -test at this time.  The purpose will be to confirm fe a-
sibility of the training conditions, to assess effect size on cognitive measures  from pre - to post - training and 
adapt number of se ssions, if warranted, a nd to monitor safety.   
 Interim analyses will be conducted to ensure the safety of the trial.  Per NIA, t his project does not meet the cr i-
teria for requiring a formal Data and Safety Monitoring Plan or Data Safety Monitoring Board be cause it is not 
a Phas e III clinical trial as defined by NIH. As a behavioral intervention study, this is a phase II efficacy trial
1.  
At interim analysis, Dr. Ji will c ompare the number of adverse events between the two randomized conditions  
to assess safety.  The two groups will also be compared on attrition rates.  Any significant differences between the two conditions in adverse events or attrition rates will be  furth er investigated by Dr. Ji .  If there is a signif i-
cant imbalance, confirmed, then Dr.Ji will report the findings t o the Clinical Trial Coordinator , Dr. Hudak, who 
is unblinded.  The Clinical Trial Coordinator will work with the IRB to decide if the study should be terminated 
early.    
 
Interim analyses will be conducted to ensure the feasibility of study intervention adherence.  If at interim ana l-
yses, less than 75% of participants randomized to an arm complete at least 16 sessions (80% of prescribed 20), the intervention arm will be deemed not feasible.  If this occurred for both arms, the study will end.   
 
Finally, interim analyses will examine the potential efficacy of  the piano training arm .  Effect sizes  and conf i-
dence intervals  for all cognitive outcome s will be calculated for pre - to post - training relative to controls.  We 
expect that the piano training arm will produce an improvement of at least d=0.25 from bas eline to post -test on 
at least one of the cognitive  measures of verbal fluency (phonemic, ca tegory or switching), Trails A or B, or 
Digit Coding, relative to active controls.  If an effect size from pre - to post - training relative to controls of this 
 34 Keys to Staying Sharp 
  Version 2 
 
 
Page 34 of 58  
 magnitude is not observed on at least one of these outcomes , we will adapt study procedures by ch anging the 
number of training sessions from 20 to 25.  In this instance number of training sessions completed will be exa m-
ined as a covariate in final analyses.  
 
9.6  Final Data Analyses  
 
Dealing with Score Distribution.  We will inspect the distribution of s cores to confirm that parametric 
statistical testing is appropriate.  In the event that distributional properties do not support parametric tests, we 
will compare the results from conventional parametric analyses with (a) results from similar nonparametric  
testing (e.g., Wilcoxon signed ranks test) , (b) results from parametric analyses co nducted after the non -normally 
distributed variables are transformed to improve normality to compare the results with the conventional par a-
metric analyses, and (c ) Any ille gal values or outliers of >= +/ -3z will be checked for accuracy with the raw d a-
ta. 
 Composite Outcomes.  Data reduction in the form of principal component factor analysis (PCA) will be used 
to derive composite outcomes of CAP ,cognition, and everyday functi on for analyses to reduce the number of 
comparisons.  Baseline data across CAP , cognitive , and everyday function outcomes will be factor analyzed u s-
ing pairwise deletions.  Based on the number of factors derived and factor loadings of the individual measur es 
(.4 or greater), outcome composite scores will be calculated  after transforming the  baseline data to z scores 
while  taking into account the directional scaling of the items.  Post -test scores will be standardized based upon 
the baseline mean and SD.  Th e baseline factors and loadings will be applied to calculate post -test composite 
scores .  
 Preliminary/Descriptive Analyses .  Prior to the analyses described below, we will conduct one -way ANOVA 
or Chi -square analyses as appropriate comparing the  randomized  groups  at baseline on age, race, education, sex, 
MoCA, GDS, hearing and vision, to ensure that the study randomization procedures were successful.  We will also confirm the equivalence of the two randomized conditions by comparing the NICT questionnaire respons-es.  The total across the six items relevant to cognition will be calculated and examin ed in analyses.   If even a 
marginally significant (p<.1) difference is observed for any of the se study variables, the  pertinent variables  will 
be included as covariates in subsequent analyses.  
 Specific Aim 1: To examine the efficacy of piano training to improve CAP, cognition, and everyday fun c-
tion among older adults .  We will compare changes in performance for piano training re lative to co ntrol  across 
the two measurement points (baseline, immediate post -test).  We will use the PCA -derived composites of CAP 
and cognition, and everyday functioning as outcomes.  We will use repeated measures analyses of variance within the mixed effects models, examining group as the between- subjects factor and time as the within -
subjects factor.  The group x time interaction will indicate whether the participants randomized to piano training change at differential rates over time r elative to those randomized to the control  group.  This output will be ob-
tained for each of the composite outcomes (CAP, cognition, and functional abilities).  For aim 1 analyses and the composite outcomes of CAP, cognition, and everyay function, w e will a pply Holm -Bonferroni 
adjustments
125 to reduce Type I error .  Speci fically, the Holm -Bonferroni procedure uses a step- down process 
whereby p -values are sorted from lowest to highest, then the lowest p- value is used in it raw version, the second 
lowest p -value is multiplied by two, the third lowest p- value is multiplied by  three and so on until the adjusted 
 35 Keys to Staying Sharp 
  Version 2 
 
 
Page 35 of 58  
 p-value reaches or exceeds the pre- specified threshold for statistical significance, in our case a two -tailed p va l-
ue of .05.  
 
Intent -To-Treat Approach.  W e expect that some participants will not complete their intended  followup a c-
cording to the protocol for a variety of reasons, ge nerating missing values.  Intent -to-treat (ITT) analysis has 
become a widely accepted method for dealing with this issue.  To maximize available information, we will employ statistical techniq ues that allow for the inclusion of missing data.  Specifically, we will use linear mixed 
effects models to analyze data.  This advanced analytical method allows for the inclusion of participants with missing data, so long as data are missing at random and offers flexibility with regard to the specification of the variance/covariance structure, which often leads to improved fit of the analytical model to the actual data.   If 
there is  non- ignorable missing data, we will apply pattern- mixture mixed effects mo dels to assess the sensitivity 
of our findings with regard to missing data  
126.   
 Specific Aim 2: To examine the moderating effects of MCI on intervention efficacy.   We will also test for 
moderation effects to determine at what stage along the cognitive status continuum —without MCI vs. MCI —
intervention is most effective.  To do so, we  will examine th ree-way interactions (MCI  x training group x time) 
for the CAP, cognitive , and everyday function composites.  When an interaction is significant, we will stratify 
analyses by MCI status  and examine effect sizes .  Effect sizes  from pre - to post - training relative to controls  will 
be compared for pa rticipants with/without MCI.  An alpha of .05 will be used for these analyses.  
 
Participants who score 26  or higher on the MoCA will be defined as no MCI (i.e., cognitively normal).  Those 
particip ants who score a 20- 25 on the MoCA will be defined as MCI if they score a 0.5 on the CDR and have 
performance at or 1 SD below the ir age, sex, and education norms  on any of the following measures:  Trails, 
Verbal Fluency, Digit Coding, Craft Story Recall, Multilingual Naming Test, or Benson Complex Figure.  
Those with MoCA scores 20- 25 who score 0 on the CDR , but have performance at or 1SD below expected for 
age, sex, and education will be adjudicated prior to analyses.  If an individual scores 20- 25 on the  MoCA, and 
0.5 on the CDR, but  has performance above expected on a ll of the aforementioned measures, their case will be 
adjudicated prior to analyses.  The study physicians will adjudicate such cases prior to coding of  MCI status for 
final analyses .   
 
To quant ify the effects of piano training further, in addition to examining composite outcomes as detailed 
above, we will calculate and report effect sizes  for pre -to-post change  of piano training relative to controls for 
each individual measure of CAP, cogni tion, and everyday function for the sample overall as well as stratified by 
MCI status and among those who were adherent only (80% or more of sessions completed) .  
 
 
Additional Analyses.  To address exploratory aim 3, with identification of significant eff ects from the analyses 
for aim 1, we will examine behavioral mediators of interventions to determine mechanisms.  We hypothesize that improved CAP will mediate cognitive gains .  We hypothesize that cognitive gains will mediate functional 
gains.  Formal med iation tests using a bootstrapping technique as outlined by Hayes
127 and Selig and 
Preacher128 will be used to examine these hypotheses.  The pre -to-post di fferences will be captured by a latent 
score128, whereby the post -test score will serve as the outcome wi th pre -test score covaried.  Results yield esti-
mates and confidence intervals for the indirect and total effects.  The procedure allows simultaneous estimation of all three pathways (M on Y; X on M; X on Y, where M=mediator (CAP score), Y=outcome (cognition), and X=predictor (group assignment)) as well as adjustment for covariates (e.g., depression).  The use of bootstra p-
ping will ensure that power  is not reduced from the main effect analyses
129.  An alpha of .05 will be used for 
these analyses.     
 36 Keys to Staying Sharp 
  Version 2 
 
 
Page 36 of 58  
  
9.7  Sensitivity Analyses  
 
Sensitivity analyses will be conducted to examine if missing data or outliers significantly affected results.  We will conduct sensitivity analysis for missing data by using pattern mixture models.  The pattern of results will be compared to ITT analyses.  Results will also be conducted after any outliers, defined as observations with va l-
ues of greater than +3 or smaller than - 3 z score units, are removed  and compared to primary results.   
 
9.8  Exploratory Subgroup Analyses   
 Pursuant to NIH guidelines on examining sex as a biological variable, we will examine if sex moderates any significant intervention effects identified in aim 1 or aim 2 analyses b y examining sex x group x time intera c-
tions.  Effect sizes will be reported by sex if there are any significant differences (alpha .05).    Relevant to aim 1 and 2 analyses, e xploratory analyses will further examine effect size  for the pre -to post -
change of piano training relative to music listening instruction among those who were adherent (i.e., who com-pleted 80% or more of assigned number of sessions) in both conditions.  Analyses detailed above for specific aims 1 and 2 will be repeated among this subsa mple.   Results and effects sizes among the adherent sample will 
be compared to the ITT derived results and effect sizes.    Relevant to aim 1 and 2 analyses, w e will further examine if effects were moderated by a better ear pure-tone 
average (PTA).  In these analyses we will examine if there are significant training group x time x hearing inte r-
actions on CAP, cognition, or everyday function, using an alpha of .05.   
As it is possible that training will be differentially effective for those with CAP disorders (CAPD), we will ide n-
tify a subgroup of participants (regardless of MCI status) who could be diagnosed with CAPD.  Diagnosis of 
(C)APD requires performance deficits on the order of at least two standard deviations below the mean on two or 
more of the following tests39, 130:  temporal processing (TCS, ATTR), degraded speech understanding (WIN), or 
binaural processing (DDT, DST).  Analyses for the cognition and everyday function outcomes will be repeated with groups defined as with/without CAPD as an independent variable.  We will examine if there are significant training group x time x ADP status interactions using an alpha of .05.   We may also explore moderation effects of covariates such as MCI subtype (amnestic, non- amnestic, multiple 
domain) to determine who is most likely to benefit from the intervention among participants with MCI.  To do so, we will examine three -way interactions (covariate x training group x time) stratified by MCI status, if MCI 
was a significant moderator in results of analyses for aim 2 described above.  Effect sizes will be examined .    
 The self -efficacy measures (general self -efficacy and music performance self -efficacy) will be examined as ex-
ploratory outcomes by comparing the two randomized conditions across the two measurement points (be-fore/after training).  Analyses will include ordinal logistic regression analyses across levels of self- eficacy co n-
ducted within the generalized estimating e quations (GEE) statistical framework to account for repeated meas-
urements.  Significant improvements on either measures demonstrated in this analyses will be followed by ex-ploratory mediation analyses to examine if improve ments in self -efficacy can account  for any observed training 
 37 Keys to Staying Sharp 
  Version 2 
 
 
Page 37 of 58  
 effects on CAP, cognition, or everyday function.  Thus, we will examine an alternative hypothesis that training 
gains can be attributed to i mproved self -efficay.  An alpha of .05 will be used.  
 To ex plore  if initial music aptitu de affects performance within each of the training conditions, AMMA at bas e-
line will be examined as a covariate (i.e., modifier) of Basic Piano Measure performance (BPM) from the first to the final day of training among those in the piano training condition.  Similarly, baseline AMMA will be e x-
amined as a covariate on the Music Listening Measure (MLM) across the same two time points within the co n-
trol group.  Again, ordinal logistic regression with GEE will be used given the ordinal scaling of the outcomes.  An alpha of .05 will be used.  
 38 Keys to Staying Sharp 
  Version 2 
 
 
Page 38 of 58  
 10 DATA COLLECTION, SITE MONITORING, AND ADVERSE EXPER I-
ENCE REPORTING  
10.1 Records to Be Kept  
 
A visit control sheet (VCS) will be the only document indicating the participants name and subject id.  This data form will be kept in a locked filing cabinet separate from the study data.  This data form will be accessible to the Testers and Trainers as well as PIs, only.    Signed consent forms will be kept in locked filing cabinets separate from the data forms and will not contain the 
subject id number.   
 
We will keep all  completed  telephone screening interviews  to track the number of screenings completed, num-
ber scheduled , and reasons ineligible.  We will keep the  data forms completed and intervention re cords, which 
will contain subje ct id only, in a locked filing cabinet.    
 All documents will be kept for at least 5 years post -study close out (or longer if required by site IRB or NIH or 
other governing body).   
  The study database will not include participant names or other identifying information.  When the study data are released for sharing, the data will be completely de -identified with any potentially ide ntifying information ( e.g., 
date of birth) removed.  
 
10.2 Data Management  
10.2.1  Clinical site responsibilities in data collection and management.  
 Each study participant will have a folder with participant id for all assessments completed for each study visit and for the intervention phase.  Every data form (page) will include the participant id and date the form was administered.   
 Origin al versions of the data forms arranged by study visit will be kept in a locked filing cabinet in the lab noted 
with an  electronic file location in the footer.  Data forms will only be copied from these origi nals only.  Each 
testing visit will include a detailed checklist of all measures to be administered and procedures to be followed, which will be initialed by the tester upon compl etion.   
 Immediately after completing a participant visit, the tester will score the asses sments and check all forms for 
comp letion, a nd within 21 days a different  tester should use a detailed checklist to review all of the data forms 
for accuracy and completion.  Any unclear or missing items are queried to the Tester or study participant as a p-
propriate.  This quality control pr ocess helps to avoid missing data.  This process will be repeated as necessary 
prior to data entry until the checklist is completed.  This rescoring process is the first step of our data quality control pr ocess.   
 
 39 Keys to Staying Sharp 
  Version 2 
 
 
Page 39 of 58  
 At the end of each testing visit and inte rvention phase , every data form will be reviewed in a five -step quality 
control audit (scoring, rescoring, entry, checking, reconciling) with each subsequent step performed by a diffe r-
ent Research Assistant.   
 The data will be entered into a custom -designed MS Access database that uses MS SQL Ser ver as the back end 
relational database and completely integrates study management (e.g., create forms, collect data, generate r e-
ports, prepare for analysis).  The database is designed to ensure access co ntrol, audit control, data integrity, user 
authentication, and transmission security.  The data quality control and custom database function to minimize missing data and e nsure data integrity.   
 Only individuals trained by the PI or Study Coordinator  to use the MS Access database will enter data.  Reports 
reflecting entered data will be printed for each testing visit of each participant  upon da ta entry .  The data report 
will be checked for accuracy with the raw data by a trained  staff member other than who entered t he data.  E r-
rors or omissions will be returned for reconciliation and the pr ocess will be repeated until  the entered data are 
deemed error free.  Additionally, a ra ndom audit of 20% of folders entered will be completed each replicate.   
11 Quality Assurance 
 The study protocol including a priori hypotheses and data analytic plan will be published online within 90 days of commencement of data collection.  Any changes to the protocol or analytic plans will be documented with date of change and justification .   
 All study staff who recruit, interview, or assess study participants will be required to attend a weekly staff meet-ing with the Principal Investigator throughout the data collection phase of the study.  Recruitment goals and procedures will be reviewed.  P roblems or issues will be discussed and resolved.  Detailed minutes of the mee t-
ings proceedings will be kept for review by any personnel who are on vacation or ill  and miss a  meeting .  If 
staff change, new personnel will review all previous study meeting m inutes prior to working on the project.  
The study coordinator will keep these records from each staff meeting.   
 The study investigators will meet about  monthly during the first quarter of the study, will meet at interim ana l-
yses, and at least annually t o review/monitor any adverse events, if they occur .  The study i nvestigators may  
also meet monthly in the final quarter of the study to complete data analysis, interpretation, and publ ication.   
 All study staff will read, be instructed in, and may be asked to pass a certification exam on the study pr otocol 
before working on assigned study activities.  All study staff will be required to complete IRB Human Subjects training prior to working on the project with re -certification completed as required by the N IH or IRB.  This 
will be monitored and implemeneted by the study c oordinator.   
 Telephone screeners will be required to complete two practice inteviews with the first actual study interview 
supervised and evaluated by the Principal Investigator, Study Coordinator, or trained and ce rtified telephone 
screener.  The Study coordinator or other site personnel appointed to do will audit the first telephone screening interview completed and will co ntinue to do so until the questionnaire and final outcome are completed without 
error.  
 
 40 Keys to Staying Sharp 
  Version 2 
 
 
Page 40 of 58  
 The Testers , who will administer the baseline , clinical  and post -test visits,  will be required to practice admi n-
istration of all study measures per the study protocol with three persons.  The testing m ust be co mpleted with at 
least tw o individuals who meet the study age requirements.  The third practice visit will be supervised by the 
Principal Investigator, Clinical Coordinator, or a trained and certified tester  (more practice may be deemed nec-
essary by the observer) .  The first actual study assessment visit will also be supervised and evaluated by one of 
these study personnel.  To further achieve internal va lidity  and inter -rater reliability , the test ers will observe  and 
evaluate each other at least once per replicate and audit each o ther’s testing records.   Participant data forms 
should be audited by a different tester within 21 days of completion per a detailed rescoring checklist.  Any 
missing, incomplete, or unclear items will be queried to the tester or participant as appropriate.   The Study C o-
ordinator will implement and monitor this process.  Additional training and certification is required to admini s-
ter the Clinical Dementia Rating Scale.    A detailed intervention protocol will be developed for T rainers.  The Trainers may  be required to pass  a certif i-
cation test of the intervention protocol prior to interacting with study participants during the i ntervention phase.  
The Trainers will be required to co mplete at least 5 hours of  training  activities that they will administer as a part 
of their training, prior to administering the intervention exercises  to actual study participants .  They will co m-
plete an initial mock training session under the observation of the PI, Study Coordinator, or another trained R e-
search Assistant Trainer p rior to conducting an actual study intervention visit.  To further achieve internal vali d-
ity and intervention fidelity, t he trainers will observe and evaluate each other at least once per replicate and a u-
dit each other’s intervention records.  The first actual intervention visit conducted by the trainer will also be s u-
pervised and evaluated by the study coordinator or a certified trainer .  Participant training data forms will be 
audited by a differe nt trainer  within 21 days of completion per a detailed resc oring checklist.  Any missing, i n-
complete, or unclear items will be queried to the trainer or participant as appropriate.   The Study Coordi nator 
will implement and monitor this process.   
 The Study coordinator  or other site personnel appointed to do will audit the first testing/intervention folder 
completed  and rescored by each tester/trainer, and will continue to do so until the procedure is completed wit h-
out error.  Random quality control audits will be performed on 2 0% of the partic ipant folders each replicate .   
 Study documents and pertinent records will be available for inspection by monitoring authorities (e.g., NIH or IRB) as requested.   
 
11.1 Adverse Experience Reporting  
 Study staff  will monitor participants and be alert to any adverse events at each study..  Testers and Trainers will 
ask participants about any adverse events  at the end of each testing and intervention visit .  Furthermore, the pa r-
ticipants  will be interviewed about any such events  throughout their study participation at the post -test v isit.  
Study staff  will be alert to any volunteered adverse event s.  All  such events will be documented on a 
standardized form.  At all in -person contacts and at any other applicable time throughout the study, any pote n-
tial adverse events reported by a sub ject or observed by the research staff will be recorded and subsequently 
evaluated by the Principal Investigator for its relation to the study research proc edures and whether or not any 
corrective action need be taken.  It is unlikely and not expected that  any adverse incident will result from im-
plementation of this study protocol.  However, any and all adverse events that may occur will be recor ded on 
the appropriate  forms, and reported to the governing IRB, as applicable.  
 41 Keys to Staying Sharp 
  Version 2 
 
 
Page 41 of 58  
  
Any adverse ev ents will be repor ted to the site  IRB within 72 hours  of occurrence or dete ction by PI Edwards.  
In the unlikely event of a serious adverse event this report will be made within 24 hours and reported also to the NIH Project Officer.  In the unlikely case of study- related serious a dverse events, an interim analysis will be 
performed in order to determine whether a change in the risk/benefit ratio has occurred and reviewed by the statistician Dr. Ji.   If so, this change will be brought to the attention of the USF IRB for revie w, current and f u-
ture participants will be notified of this change, and stopping rules will be considered.  
 
11.2 Follow -up for Adverse Events  
Research Assistants will monitor participants for any adverse events at study visits.  At the post -test study visit, 
participants will be directly interviewed about any possible adverse events that occurred since their initial visit.  A study physician and/or Dr. Edwards  will follow -up with the participant for any adverse events.  The partic i-
pant will be referred to prope r treatment.  
 
11.3 Safety Monitoring  
The PI  and the Study Physicians  will be responsible for ensuring participants’ s afety.  
 Dr. Ji will perform analyses to  monitor participant safety, evaluate the progress of the study, to review proc e-
dures for maintaining t he confidentiality of data, the quality of data collection, management, and analyses.  
 All OHRP and local IRB requirements for r eporting adverse events will be followed.   
 
11.4 Confidentiality  
 All evaluation forms, reports, recordings, and other records that  leave the site will be identified only by the pa r-
ticipant id number  to maintain subject confidentiality.  All records will be kept in a locked file cabinet.   All 
computer entry of data forms will be done using participant ids only and without partic ipant names .  Clinical 
information will not be released without written permission of the participant , except as necessary for monitor-
ing by IRB, NIH , or the OHRP   
11.5 Study Modification/Discontinuation  
 The study may be modified or discontinued a t any time by the I RB, the NIH , the OHRP, or other government 
agencies as part of their duties to ensure that r esearch subjects are protected.  
 Study Modifications  
Date  Imple-
mented  Modification  Rationale  
04/23/2018  For the pilot replicate, the FAS, 
Animals/ Boys’ Names, and Fruits/ Furniture version will be 
administered at baseline and The music listening condition 
involves a lesson on musical intstruments. Thus, we decided 
that using this version  of verbal 
 42 Keys to Staying Sharp 
  Version 2 
 
 
Page 42 of 58  
 also at post test.  fluency category switching  at 
post would unfairl y bias the ac-
tive control condition. We did 
not realize this until during the 
training phase of the pilot repl i-
cate. We changed the order for 
furture replicates such that Veg-etables/Musical Instruments version is administered at bas e-
line and the Fruits/Fur niture ver-
sion will be administered at 
post-test. 
07/16 /2018  Page 12, 5.2 E xclusion Criteria.  
We clarified that individuals who have prev iously participated in 
the USF Music Research and Testing Lab studies are exclu d-
ed.  This was inadvertently omitted 
from the protocol version 1. All 
individuals screened for the study were excluded if they r e-
ported prior participation in the Music Research and Testing Lab. The rationale is s uch indi-
viduals would have completed similar or the same measures as administered in this study 
and may have received music 
training. 
07/16/ 2018  Page 15,  5.7 Interventions A d-
ministration and D uration.  We 
omitted the sentence that indi-cated a textbook will be provi d-
ed and weekly homework will be assigned.  The study inve stigators met to 
discuss the study progress and any modifications needed since completion of the pilot rep licate. 
The trainers and a Co- I noted 
that it was difficult to make the homework assignments and en-gagment equiv alent across the 
two conditions. It was decided that we will omit the homework 
for replicate 1 and the remai n-
der of the study.  Participants 
will only access the textbooks during the in -lab training ses-
sions. There is no evidence that 
homework is r equired for piano 
training to be efficacious.  E n-
suring equi valency of the two 
conditions is the rationale.  
07/16 /2018  Page 12, 5.2 Exclusion criteria. 
We added, “which interferes The PI and study coordinator 
felt the exclusion criteria of any 
 43 Keys to Staying Sharp 
  Version 2 
 
 
Page 43 of 58  
 with ability to use a keyboard” to 
exclusion criteria regarding 
numbness or tingling.  numbness or tingling in any fi n-
ger was too conservative and 
that individuals were being ex-
cluded that would be able to successfully participate in the study.  We deci ded to add this 
phrase in an attempt to only ex-clude those who would not be able to successfully complete 
the interve ntion.  
07/16/2018  Pages 13 -14, 5.3 Enrollment 
Procedures.  Those who score a 26 or better on the MoCA will be enrolled in the study (not 27). 
Those potentially eligible who score between 20 to 25 (not 26) on the MoCA who were not r e-
ferred by the MDC or study phy-sician will also complete a clin i-
cal evalu ation visit.   The PI and Study Coordinator 
felt the criteria for clinical eval u-
ation were too stringent . The 
study investigators deci ded to 
use the traditional cut -point of 
26 for MoCA to deter mine who 
is eligible and who requires fur-ther evaluation.   
07/30/2018  Page 14, 5.3 Enrollment Proc e-
dures.  We clarify that c linically 
significant abnormalities are shared with the participants who are encouraged to seek treat-ment.  We added the phrase, 
“that would likely interfere with their ability to benefit from inter-vention”  regarding any signif i-
cant clinical abnorma lities.  This has been our procedure 
beginning in replicate 1.  The 
goal is to be inclusive and to al-low tho se who could potentially 
benefit from intervention to con-tinue partic ipation in the study.  
 
 44 Keys to Staying Sharp 
  Version 2 
 
 
Page 44 of 58  
 12 REFERENCES  
 
1. Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M Reenvisioning Clinical Science: Unifying 
the discipline to improve the public health  Clinical Psychological Science 2014;2(1):22- 34  doi: 
10.1177/216770261349793225821658 2. Gates GA, Gibbons LE, McCurry SM, Crane PK, Feeney PK, Larson EB Executive dysfunction and 
presbycusis in older persons with and without memory loss and dementia  Cognitive and Behavioral Neurology 2010;23:218- 23  doi: 10.1097/WNN.0b013e3181d748d7 
3. Gates GA, Anderson ML, Feeney MP, McCurry SM, Larson EB Central auditory dysfunction in older 
persons with memory impairment or Alzheimer dementia  Archives of  Otolaryngology -- Head and Neck 
Surgery 2008;134(7):771 -72008/07/23  doi: 10.1001/archotol.134.7.77118645130 
4. Gold M, Lightfoot LA, Chisolm T Hearing loss in a memory disorders clinic:  A specially vulnerable 
population Archives of Neurology 1996;53:922- 8  
5. Albers MW, Gilmore GC, Kaye JA, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, 
Cruickshanks K, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm TH, Holtzer R, Hyman B, Lin F, McKee JQ, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang L I At the interface of sensory and motor 
dysfunctions and Alzheimer's disease  Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2015;11:70- 98  doi: 10.1016/j.jalz.2014.04.514 
6. Gates GA, Beiser A, Rees T, D'Agostino R, Wolf P Central audi tory dysfunction may precede the onset 
of clinical dementia in people with probable Alzheimer's disease  Journal of the American Geriatrics Society 2002;50:482- 8  doi: 10.1046/j.1532- 5415.2002.50114.x 
7. Gates GA, Cobb J, Linn R, Rees T, Wolf P, D'Agostino R Central auditory dysfunction, cognitive 
dysfunction, and dementia in older people  Archives of Otolaryngology --  Head and Neck Surgery 
1996;122:161- 7  doi: 10.1001/archotol.1996.01890140047010 
8. Schneider BA, Pichora -Fuller MK. Implications of perceptual deterioration for cognitive aging research. 
In: Craik FIM, Salthouse TA, editors. The Handbook of Aging and Cognition. Mahwah, NJ: Lawrence Erlbaum 
Associates, Inc; 2000. p. 155- 220. 
9. Nikjeh D, Lister J, Frisch S Hearing of note:  An electrophysiologi c and psychoacoustic comparison of 
pitch discrimination between vocal and instrumental musicians  Psychophysiology 2008;45:994- 1007  
10. Nikjeh D, Lister J, Frisch S Pre -attentive cortical evoked responses to pure tones, music, and speech: 
Influence of mus ic training  Ear and Hearing 2009;30:432- 46  
11. Alain C, Bidelman G Musical Training Orchestrates Coordinated Neuroplasticity in Auditory Brainstem 
and Cortex to Counteract Age -Related Declines in Categorical Vowel Perception  Journal of Neuroscience 
2015;35(3):1240- 9  
12. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg B Mild cognitive impairment 
represents early -stage Alzheimer's disease  Archives of Neurology 2001;58:397- 405  doi: 
10.1001/archneur.58.3.397. 13. Corner L, Bond J Bei ng at risk of dementia: Fears and anxieties of older adults  Journal of Aging studies 
2004;18:143- 55  doi: 10.1016/j.jaging.2004.01.007 
14. Seshadri S, Wolf PA Lifetime risk of stroke and dementia: Current concepts, and estimates from the 
Framingham Study  Lancet Neurology 2007;6(12):1106- 14  doi: 10.1016/S1474- 4422(07)70291- 018031707 
15. Sands LP, Yaffe K, Lui LY, Stewart A, Eng C, Covinsky K The effects of acute illness on ADL decline 
over 1 year in frail older adults with and without cognitive impairment   Journals of Gerontology Series A, 
Biological Sciences and Medical Sciences 2002;57:M449- M54  
 45 Keys to Staying Sharp 
  Version 2 
 
 
Page 45 of 58  
 16. Kirschstein R. Disease -specific estimates of direct and indirect costs of illness and NIH support: Fiscal 
year 2000 update: National Institute of Health; 2000. Available from: 
http://ospp.od.nih.gov/ecostudies/COIreportweb.htm . 
17. Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM Monetary costs of dementia in the United States  New England Journal of Medicine 2013;368(14):1326-34  doi: 10.1056/NEJMsa120462923550670 18. Hobbs FB. Population of the United States 2008. Available from: http://www.census.gov/population/www/pop-profile/elderpop.html
. 
19. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M Global prevalence of dementia: A Delphi consensus study  Lancet 2005;366:2112-7  doi: 10.1016/S0140-6736(05)67889-0 20. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM Forecasting the global burden of Alzheimer's disease  Alzheimer's & Dementia 2007;3:181 -91  doi: 10.1016/j.jalz.2007.04.381 
21. DeCarli C M ild cognitive impairment: Prevalence, prognosis, aetiology, and treatment  The Lancet 
Neurology 2003;2:15-21  doi: 10.1016/S1474-4422(03)00262-X 22. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos E, Kokmen E Mild cognitive impairment: Clinical characterization and outcome  Archives of Neurology 1999;56:303-8  doi: 10.1001/archneur.56.3.303 23. Petersen RC Mild cognitive impairment as a diagnostic entity  Journal of Internal Medicine 
2004;256(3):183-94  doi: 10.1111/j.1365-2796.2004.01388.x 24. Reuter -Lorenz PA, Park DC How does it STAC up? Revisiting the scaffolding theory of aging and 
cognition  Neuropsychology Review 2014;24(3):355-70  doi: 10.1007/s11065-014-9270-925143069 25. Belleville S Cognitive training for persons with mild cognitive impairment  International 
Psychogeriatrics 2008;20(1):57-66  doi: 10.1017/S104161020700631X 26. Stott J, Spector A A review of the effectiveness of memory interventions in mild cognitive impairment (MCI)  International Psychogeriatrics 2010;23:526-38  doi: 10.1017/S1041610210001973  27. American Speech Language Hearing Association. Guidelines for manual pure-tone threshold audiometry [guidelines]. 2005. 28. Gates GA, Gibbons LE, McCurry SM, Crane PK, Feeney MP, Larson EB Executive dysfunction and presbycusis in older persons with and without memory loss and dementia  Cognitive and Behavioral Neurology 2010;23(4):218-23  doi: 10.1097/WNN.0b013e3181d748d721150347 29. Li KZH, Lindenberger U Relations between aging sensory/sensorimotor and cognitive functions  Neuroscien ce and Biobehavioral Reviews 2002;26(7):777-83  doi: 10.1016/S0149-7634(02)00073-8 
30. Fabrigoule C, Rouch I, Taberly A, Letenneur L, Commenges D, Mazaux J, Orgogozo J, Dartigues JF Cognitive process in preclinical phase of dementia  Brain 1998;121(1):135-41  31. Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease  Journal of the International Neuropsychological Society 2008;14(2):266-78  doi: 10.1017/S135561770808030218282324 32. Belleville S, Chertkow H, Gauthier SUS  Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairmentUSUS   NeuropsychologyUS  2007;21(4):458-69US Epub US   doi: 10.1037/0894-4105.21.4.458US PubMed PMID: US 33. Stopford CL, Thompson JC, Neary D, Richardson AM, Snowden JS Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia  Cortex 2010;48(4)2011/01/18  doi: 10.1016/j.cortex.2010.12.002 21237452 34. Gates GA, Beiser A, Rees TS, D'Agostino RB, Wolf PA Central auditory dysfunction may precede the onset of clinical dementia in people with probable Alzheimer's disease  Journal of the American Geriatrics Society 2002;50(3):482-8 11943044 
 46 Keys to Staying Sharp 
  Version 2 
 
 
Page 46 of 58  
 35. Gates GA, Anderson ML, McCurry SM, Feeney MP, Larson EB Central auditory dysfunction as a 
harbinger of Alzheimer dementia  Arch Otolaryngol Head Neck Surg 2011;137(4):390- 5  doi: 
10.1001/archoto.2011.2821502479 
36. Humes LE, Dubno JR, Gordon- Salant S,  Lister JJ, Cacace AT, Cruickshanks KJ, Gates GA, Wilson RH, 
Wingfield A Central presbycusis: A review and evaluation of the evidence  Journal of the American Academy of Audiology 2012;23(8):635- 66  doi: 10.3766/jaaa.23.8.522967738 
37. Edwards JD, Lister J J, Elias MN, Tetlow AM, Sardina AL, Sadeq NA, Brandino AD, Harrison Bush AL 
Auditory processing of older adults with probable mild cognitive impairment  Journal of Speech, Language, and Hearing Research 2016  
38. Idrizbegovic E, Hederstierna C, Dahlquist M , Kampfe Nordstrom C, Jelic V, Rosenhall U Central 
auditory function in early Alzheimer's disease and in mild cognitive impairment  Age and Ageing 2011;40(2):249- 54  doi: 10.1093/ageing/afq16821233090 
39. Association AS -L-H. Guidelines for manual pure -tone threshold audiometry [guidelines]. 2005.  
40. American Speech -Language -Hearing Association. Central auditory processing: Current status of status 
of research and implications for clinical practice. 1996. 41. Pichora -Fuller MK, Singh G Effects of age on aud itory and cognitive processing: Implications for 
hearing aid fitting and audiologic rehabilitation  Trends in Amplification 2006;10:29- 59  doi: 
10.1177/108471380601000103  42. Anderson S, White -Schwoch T, Parbery- Clark A, Kraus N Reversal of age- related neural timing delays 
with training  Proceedings of the National Academy of Sciences of the United States of America 2013;110(11):4357- 62  doi: 10.1073/pnas.121355511023401541 
43. Pichora -Fuller MK, Schneider BA, Daneman M How young and old adults listen to a nd remember 
speech in noise  Journal of the Acoustical Society of America 1995;97:593- 608  
44. Rabbitt PM Channel -capacity, intelligibility and immediate memory  Quarterly Journal of Experimental 
Psychology 1968;20(3):241- 8  doi: 10.1080/146407468084001585683763 
45. Tun PA, McCoy S, Wingfield A Aging, hearing acuity, and the attentional costs of effortful listening  
Psychology and Aging 2009;24(3):761- 6  
46. Grimes AM, Grady CL, Foster NL, Sunderland T, Patronas NJ Central auditory function in Alzheimer's 
disease  Neurology 1985;35(3):352- 8 3871922  
47. Jäncke L, Shah NJ Does dichotic listening probe temporal lobe functions?  Neurology 2002;58(5):736-
43  48. Duchek JM, Balota DA Failure to control prepotent pathways in early stage dementia of the Alzheimer's 
type: Evidence from dichotic listening  Neuropsychology 2005;19(5):687- 95  doi: 10.1037/0894-
4105.19.5.68716187887 
49. Kurylo DD, Corkin S, Allard T, Zatorre RJ, Growdon JH Auditory function in Alzheimer's disease  
Neurology 1993;43(10):1893- 9 8413944 
50. Sinha UK, Hollen KM, Rodriguez R, Miller CA Auditory system degeneration in Alzheimer's disease  
Neurology 1993;43(4):779- 85 8469340 
51. De Santia S, de Leona MJ, Rusinekb H, Convita A, Tarshisha CY, Rochea A, Tsuic WH, Kandila E, 
Boppanna M, Daisleya K, W angd GJ, Schlyere D, Folere J, al. e Hippocampal formation glucose metabolism 
and volume losses in MCI and AD  Neurobiology of Aging 2001;22(4): 529–39  doi: 10.1016/S0197-
4580(01)00230- 5 
52. Wingfield A, Peelle J The effects of hearing loss on neural processing and plasticity  Frontiers in 
Systems Neuroscience 2015;9:1- 4  
53. Rauschecker JP, Scott SK Maps and streams in the auditory cortex: nonhuman primates illuminate 
human speech processing  Nature Neuroscience 2009;12:718- 24  doi: 10.1038/nn.2331 
 47 Keys to Staying Sharp 
  Version 2 
 
 
Page 47 of 58  
 54. Davis MH, Johnsrude I Hierarchical processing in spoken language comprehension  The Journal of 
Neuroscience 2003;23(8):3423- 31  
55. Eckert MA, Cute SL, Vaden KI, Jr., Kuchinsky SE, Dubno JR Auditory cortex signs of age -related 
hearing loss  Journal of the As sociation for Research in Otolaryngology 2012;13(5):703- 13  doi: 
10.1007/s10162- 012-0332- 522618352 
56. Wong PC, Perrachione TK, Parrish TB Neural characteristics of successful and less successful speech 
and word learning in adults  Human Brain Mapping 2007;28(10):995- 1006  doi: 10.1002/hbm.2033017133399 
57. Gates GA, Cobb JL, Linn RT, Rees T, Wolf PA, D'Agostino RB Central auditory dysfunction, cognitive 
dysfunction, and dementia in older people  Archives of Otolaryngology --  Head and Neck Surgery 
1996;122( 2):161- 7 8630210 
58. Anderson S, Kraus N Auditory training: Evidence for neural plasticity in older adults  Perspectives in 
Hearing and Hearing Disorders: Research and Diagnostics 2013;17:37- 57  doi: 10.1044/hhd17.1.3725485037 
59. Zendel BR, Alain C Musici ans experience less age- related decline in central auditory processing  
Psychology and Aging 2012;27(2):410- 7  doi: 10.1037/a002481621910546 
60. Mishra SK, Panda MR, Herbert C Enhanced auditory temporal gap detection in listeners with musical 
training  Journal of the Acoustical Society of America 2014;136(2):EL173 -EL8  
61. Kraus N, Chandrasekaran B Music training for the development of auditory skills  Nature Reviews 
Neuroscience 2010;11:599- 605  doi: 10.1038/nrn2882 
62. Humes LE, Busey TA, Craig J, Kewley -Port D Are age- related changes in cognitive function driven by 
age-related changes in sensory processing?  Attention, Perception, & Psychophysics 2013;75(3):508- 24  doi: 
10.3758/s13414- 012-0406- 923254452 
63. Mahncke HW, Bronstone A, Merzenich M Brain plast icity and functional losses in the aged:  Scientific 
bases for a novel intervention  Progress in Brain Research 2006;157:81- 109  
64. Edwards JD, Clark D, Xu H, Unverzagt FW Computerized process -based training reduces dementia 
prevalence over ten years  (in  preparation)  
65. Park DC, Lodi -Smith J, Drew L, Haber S, Hebrank A, Bischof GN, Aamodt W The impact of sustained 
engagement on cognitive function in older adults: The Synapse Project  Psychological Science 2014;25(1):103-
12  doi: Doi 10.1177/0956797613499592WOS:000329486300011 66. Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, Kulansky G, Ambrose A, Sliwinski M, Buschke 
H Leisure activities and risk of dementia in the elderly  New England Journal of Medicine 2003;348:2508- 16  
doi: 10.1056/NEJMoa022252 67. Seinfeld S, Figueroa H, Ortiz -Gil J, Sanchez -Vives MV Effects of music learning and piano practice on 
cognitive function, mood, and quality of life in older adults  Frontiers in Psychology 2013;4  doi: 
10.3389/psyg.2013.00810 
68. Paquette S, Goulet GM  Lifetime benefits of musical training  Frontiers in Neuroscience 2014;8:1 -2  doi: 
10.3389/fnins.2014.00089 
69. Alain C, Zendel BR, Hutka S, Bidelman GM Turning down the noise: The benefit of musical training on 
the aging auditory brain  Hearing Research 2014;308:162- 73  doi: 10.1016/j.heares.2013.06.00823831039 
70. Oechslin MS, Descloux C, Croquelois A, Chanal J, Van De Ville D, Lazeyras F, James CE 
Hippocampal volume predicts fluid intelligence in musically trained people  Hippocampus 2013;23(7):552- 8  
doi: 10.1002/hipo.2212023519979 71. Wan CY, Schlaug G Music making as a tool for promoting brain plasticity across the lifespan.  
Neuroscientist 2010;16:566- 77  doi: 10.1177/1073858410377805 
72. Bidelman GM, Weiss MW, Moreno S, Alain C Coordinated plasticity in brainstem and auditory cortex 
contributes to enhanced categorical speech perception in musicians  European Journal of Neuroscience 2014;40(4):2662- 73  doi: 10.1111/ejn.1262724890664 
 48 Keys to Staying Sharp 
  Version 2 
 
 
Page 48 of 58  
 73. James CE, Michel CM, Britz J, Vuilleumier P, Hauert CA Rhythm evokes action: Early processing of 
metric deviances in expressive music by experts and laymen revealed by ERP source imaging  Human Brain Mapping 2012;33(12):2751-67  doi: 10.1002/hbm.2139721932257 74. Strait DL, Chan K, Ashley R, Kraus N Specialization among the specialized: Auditory brainstem function is tuned in to timbre  Cortex 2012;48(3):360-2  doi: 10.1016/j.cortex.2011.03.01521536264 75. O'Brien JL, Nikjeh D, Lister J Interaction of musicianship and aging: A comparison of cortical auditory evoked potentials  Behavioural Neurology 2015;2015:1-12  doi: dx.doi.org/10.1155/2015/545917 76. Parbery -Clark A, Strait DL, Hittner E, Kraus N Musical training enhances neural processing of binaural 
sounds  The Journal of Neuroscience 2013;33(42):16741-7  doi: 10.1523/JNEUROSCI.5700-12.201324133275 77. Seidler RD Differential effects of age on sequence learning and sensorimotor adaptation  Brain Research Bulletin 2006;70(4-6):337-46  doi: 10.1016/j.brainresbull.2006.06.00817027769 78. Seidler RD, Bernard JA, Burutolu TB, Fling BW, Gordon MT, Gwin JT, Kwak Y, Lipps DB Motor control and aging: links to age- related brain structural, functional, and biochemical effects  Neuroscience and 
Biobehavioral Reviews 2010;34(5):721-33  doi: 10.1016/j.neubiorev.2009.10.00519850077 79. Han Y, Yang H, Lv YT, Zhu CZ, He Y, Tang HH, Gong QY, Luo YJ, Zang YF, Dong Q Gray matter density and white matter integrity in pianists' brain: A combined structural and diffusion tensor MRI study  Neuroscience Letters 2009;459(1):3-6  doi: 10.1016/j.neulet.2008.07.05618672026 80. Bangert M, Schlaug G Specialization within the specialized in features of external human brain 
morphology  European Journal of Neuroscience 2006;24:1832-4  81. Bugos JA The benefits of music instruction on processing speed, verbal fluency, and cognitive control in aging  Music Education Research International 2010;4(1- 9)  
82. Bugos JA, Perlstein WM, McCrae CS, Brophy TS, Bedenbaugh PH Individualized piano instruction enhances executive functioning and working memory in older adults  Aging and Mental Health 2007;11(4):464-71  doi: 10.1080/1360786060108650417612811 83. Bernard JA, Seidler RD Relationships between regional cerebellar volume and sensorimotor and cognitive function in young and older adults  Cerebellum 2013;12(5):1-30  doi: 10.1007/s12311-013-0481-z 84. Miendlarzewska EA, Trost WJ How musical training affects cognitive development: Rhythm, reward, and other modulating variables.  Frontiers in Neuroscience 2014;7(1-18)  doi: 10.3389/fnins.2013.00279 85. Seppanen M, Pesonen AK, Tervaniemi M Music training enhances the rapid plasticity of P3a/P3b event-related brain potentials for unattended and attended target sounds  Attention, Perception, and Psychophysiology 2012;74(3):600-12  doi: 10.3758/s13414-011-0257-922222306 86. Hanna-Pladdy B, Gajewski B Recent and past musical activity predicts cognitive aging variability: Direct comparison with general lifestyle activities  Frontiers in Human Neuroscience 2012;6:1 -11  
87. Hanna-Pladdy B, MacKay A The relation between instrumental musical activity and cognitive aging  Neuropsychology 2011;25(3):378-86  doi: http://dx.doi.org/10.1037/a0021895
  
88. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment  Journal of the American Geriatrics Society 2005;53:695–9  89. Good-Lite. Sloan letter near vision card: Good-Lite; 2010 [October 21, 2010]. A vailable from: 
www.good- lite.com
. 
90. Conradsson M, Rosendahl E, Littbrand H, Gustafson Y, Olofsson B, Lovheim H Usefulness of the Geriatric Depression Scale 15 -item version among very old people with and without c ognitive impairment  
Aging & Mental Health 2013;17(5):638-45  doi: 10.1080/13607863.2012.75823123339600 91. Friedman B, Heisel MJ, Delavan RL Psychometric properties of the 15- item geriatric depression scale in 
functionally impaired, cognitively intact, community -dwelling elderly primary care patients  Journal of the 
American Geriatrics Society 2005;53(9):1570-6  doi: 10.1111/j.1532-5415.2005.53461.x16137289 
 49 Keys to Staying Sharp 
  Version 2 
 
 
Page 49 of 58  
 92. Bugos JA, Groner A The effects of instrumental training on non- verbal reasoning in eighth- grade 
students  Research Perspectives in Music Education 2009;14:14- 9  
93. Wilson RH Development and use of auditory compact discs in auditory evaluation  Journal of 
Rehabilitation Research and Development 1993;30(3):342- 51  
94. Wilson RH, Salomon DL, Sperry JL, Bornstein SP Effects of time compression and time compression 
plus reverberation on the intelligibility of Northwestern University Auditory Test No.6  Journal of the American 
Academy of Audiology 1994;5:269- 77  
95. Konkle DF, Beasley DS, Bess FH Intelligi bility of time -altered speech in relation to chronological aging  
Journal of Speech, Language, and Hearing Research 1977;20(1):108- 15  doi: 10.1044/jshr.2001.108 
96. Beasley DS, Bratt GW, Rintelmann WF Intelligibility of time -compressed sentential stimuli  Journal of 
Speech, Language, and Hearing Research 1980;23:722- 31  doi: 10.1044/jshr.2304.722 
97. Wilson RH Development of a speech in multitalker babble paradigm to assess word- recognition 
performance  Journal of the American Academy of Audiology 2003;14: 453-70  
98. Finney DJ. Statistical method in biological assay. 3rd ed. London: Charles Griffin & Co. Ltd; 1964. 
99. Wilson RH, Morgan DE, Dirks DD A proposed SRT procedure and its statistical precedent  Journal of 
Speech and Hearing Disorders 1973;38:184- 91  
100. Wilson RH, McArdle R Intra - and inter -session test, retest reliability of the Words -in-Noise (WIN) Test  
Journal of the American Academy of Audiology 2007;18(10):813- 25  
101. Wilson RH, McArdle RA, Smith SL An evaluation of the BKB -SIN, HINT, QuickSIN, and WIN 
materials on listeners with normal hearing and listeners with hearing loss.  Journal of Speech, Language, and Hearing Research 2007;4:844  102. Strouse A, Hall JW, 3rd Test -retest reliability of a dichotic digits test for assessing central aud itory 
function in Alzheimer's disease  Audiology 1995;34(2):85- 90  
103. Speaks C, Jerger J, Jerger S Performance -intensity characteristics of synthetic sentences. Journal of 
Speech, Language, and Hearing Research  Journal of Speech, Language, and Hearing R esearch 1966;9(2):305-
12  doi: 10.1044/jshr.0902.305 104. Gates GA, Anderson ML, McCurry SM, Feeney MP, Larson EB Central auditory dysfunction as a 
harbinger of Alzheimer dementia  Archives of Otolaryngology -  Head and Neck Surgery 2011;137(4):390- 5  
doi: 10.1001/archoto.2011.2 105. Lister J, Roberts R, Shackelford J, Rogers C An adaptive clinical test of temporal resolution  American 
Journal of Audiology 2006;15:133- 40  doi: 10.1044/1059- 0889(2006/017)  
106. Lister J, Roberts RA, Krause JC, DeBiase D, Carls on H An adaptive clinical test of temporal resolution: 
Within -channel and across -channel gap detection  International Journal of Audiology 2011;50:375- 84  doi: 
10.3109/14992027.2010.551217 
107. Lister J, Roberts RA, Lister FL An adaptive clinical test of temporal resolution: Age effects  
International Journal of Audiology 2011;50(6):367- 74  doi: 10.3109/14992027.2010.551218 
108. Cox R A structured approach to hearing aid selection  Ear and Hearing 1985;6(5):226- 39  
109. Delis DC, Kaplan E, Kramer JH. Delis -Kaplan Executive Function System (D -KEFS). San Antonio, 
TX: The Psychological Corporation; 2001. 110. Ruff RM, Light RH, Parker SB Benton Controlled Oral Word Association Test: Reliability and updated 
norms  Archives of Clinical Neuropsychology 1996;11:329- 38  
111. Duff Canning SJ, Leach DL, D. S, Ngo L, Black SE Diagnostic utility of abbreviated fluency measured 
in Alzheimer disease and vascular dementia  Neurology 2004;62:556- 62  doi: 10.1212/WNL.62.4.556 
112. Strauss ME, Sherman EM, Spreen O. A compendium of neuropsychological tests: Administration, 
norms, and commentary. 3rd ed: Oxford University Press; 2006. 
 50 Keys to Staying Sharp 
  Version 2 
 
 
Page 50 of 58  
 113. Reitan RM, Wolfson D. The Halstead -Reitan Neuropsychological Test Battery. Tucson, AZ: 
Neuropsychological Press; 1985. 
114. Lezak MD. Neuropsychological Assessment. 3rd ed. New York: Oxford University Press; 1995. 115. Owsley C, Sloane ME, McGwin G, Ball KK Timed instrumental activities of daily living tasks: 
Relationship to cognitive function and everyday performance assessments in older adults  Gerontology 2002;48(4):254-65  doi: 10.1159/000058360 116. Robertson IH, Ward T, Ridgeway V, Nimmo- Smith I The test of everyday attention (TEA)  Test 
Reviews 2001;4(1):51-5  117. Robertson IH, Ward T, Ridgeway V, Nimmo-Smith I. The Test of Everyday Attention Manual: Pearson Assessment; 1994. 32 p. 118. Gordon EE. Advanced Measures of Music Audiation. Chicago, IL: GIA Publications; 1989. 119. Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Robers RW The self- efficacy scale:  
Construction and validation  Psychological Reports 1982;51:663-71  120. Zelenak M Development and validation of the Music Performance Self -Efficacy Scale  Music Education 
Research International 2010;4:31-43  121. Bugos JA, Kochar S, Maxfield N Intense piano training on se lf-efficacy and physiological stress in 
aging  Psychology of Music 2016:1-14  doi: 10.1177/0305735615577250 122. Rabipour S, Davidson PS Do you believe in brain training? A questionnaire about expectations of computerized cognitive training  Behavioural Brain Research 2015  doi: 10.1016/j.bbr.2015.01.00225591472 123. Faul F, Erdfelder E, Lang AG, Buchner A G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences  Behavior Research Methods 2007;39(2):175-912007/08/19  doi: 10.3758/BF0319314617695343 124. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988. 125. Holm S A simple sequentially rejective multiple test procedure  Scandinavian Journal of Statistics 
1979;6:65-70  126. Roderick JA, Rubin DB, editors. Statistical Analysis with Missing Data. 2nd ed2002. 127. Hayes AF. PROCESS: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling [White paper]. 2012. 128. Selig JP, Preacher KJ Mediation models for longitudinal data in developmental research  Reseach in Human Development 2009;6(2-3):144-64  129. Fritz MS, MacKinnon DP Required sample size to detect the mediated effect  Psychological Science 
2007;18:223-39  doi: 10.1111/j.1467-9280.2007.01882.x 130. Chermak GD, Musiek FE. Central auditory processing disorders: New perspectives. San Diego, CA: Singular1997.  13. Data availab ility: The data from this study are publicly available. Please contact P I Edwards at 
jed-
wards 1@usf.edu to request the data.    
 14. R esults  
 
Recruitment and enrollment began in January 2018 and continued through December 2020, with data 
collection completed in April 2021. Seventy -six pe rcent  of randomized participants completed post- test. Nine-
 51 Keys to Staying Sharp 
  Version 2 
 
 
Page 51 of 58  
 teen participants were excluded from analyses due to  a head injury ( n=1), undergoing anesthesia ( n=10), or 
hospitalization ( n=8) before post -test. Please see Figure 1 for details.  
The randomized gr oups did not differ in sex, χ2(1)=.787, p=.375, ethnicity χ2(1)=.167, p=.683, or race, 
χ2(1)=.045, p=.832. The Music Reading Assessment scores did not differ between the two groups, t(266)= -.958, 
p=.338. The randomized groups did not signi ficantly differ i n age, F (1,266)=.293, p=.589, education, 
F(1,266)=.369, p =.544, MoCA, F(1,266)=.427, p =.514, or GDS, F (1,266)=.943, p=.332. However, there were 
marginally significant group differences for PTA in the left ear, F (1,266)=3.31, p=.070 and sta tistically signif i-
cant group differences for both PTA in the right ear, F (1,266)=6.69, p=.010, and visual acuity, F (1,266)=8.99, 
p=.003. The music listening group tended to have worse hearing, while the piano training group tended to have 
worse visual acui ty. See Table 1. The groups also differed significantly in their expectations regarding potential 
benefits of their r andomized group, F (1,214)=15.07, p<.001. The piano training group had an average rating of 
5.55 while the music listening group had an aver age rating of 4.99, indicating the piano training condition had 
higher expectations about the potential effects of their randomized condition. The pian o training group also rat-
ed their condition as more challenging with 92% agreeing that the intervention w as challenging as  compared to 
86.3% of the music listening group indicating their condition was challenging ( p<.001) . 
Principal component analysis with varimax rotation was conducted to reduce the number of variables for 
analyses. Please see Supplemental T able A  for detail s. The first factor reflected cognitive performance speed 
and included the Trail Making Test, Digit Coding, and the TEA visual elevator and phone search subtests. The second factor included all three verbal fluency subtests. The third fact or reflected CAP and included DDT, DSI, 
TCS, and WIN. The fourth factor included two indices from the TEA phone search while counting and visual elevat or accuracy. The fifth composite included ATTR across - and within-  channel performance. Baseline com-
posit es of cognitive performance, verbal fluency, ATTR, CAP, and everyday function were created by averag-
ing z scores after the reverse- scaling of items with negative factor loadings. Post -test scores were standardized 
 52 Keys to Staying Sharp 
  Version 2 
 
 
Page 52 of 58  
 by baseline means and SD s. Timed IADL perf ormance did not s ignificantly load on any factor and was thus ex-
amined separately.  
In the primary analyses, we examined whether performance changed di fferentially by random assign-
ment across composite outcomes from baseline to post -test as indicated by a significant group- by-time interac-
tion. Covariates included hearing PTA, visual acuity, and expectations. The group- by-time interactions were not 
statis tically significant for any of the outcomes ( ps>.194). See Table 2. The results did not change when we in-
cluded only those  who were adherent ( ps>.180). See Supplementary Table B. Piano training did not significant-
ly enhance CAP, cognition, or everyday function as compared to music listening. We further examined if inter-
vention effects varied by MCI status  (Supplementary Table  B). There were no significant group- by-time-by-
MCI status interactions indicating those with and without MCI did not show differential benefit ( ps>.245). 
Thus, MCI did not significantly moderate the effects of piano training.  
Effect sizes for piano training as compared to music listening are shown in Table 3 . Improvements were 
not evident in the primary anal yses, adherent analyses, or the subsample without MCI on measures of CAP, 
cognition, or everyday function. Participants with MCI randomized to piano t raining showed potential small 
effect sizes for improvement relative to music listening on Trails A, Digit Symbol Coding, and one subtest of the TEA ( ds>=0.25). Raincloud plots of individual assessment and composite variables are included in the sup-
plement al materials.  
Results indicated significant effects of time for ATTR in all models and significant effects of time for 
CAP in the primary and adherent analyses indicating improved performance from pre - to post - training. Signifi-
cant effects of time were f ound for cognition and TEA in the primary and adherent analyses, indicating a ten-
dency for decline across time. With respect to covariate effects, CAP, ATTR, and cognitive performance were significantly impacted by hearing. Similarly, Time d IADL and cognit ive performance varied significantly by 
visual acuity. Those with poorer hearing or vision tended to perfo rm worse on these outcomes. Interestingly, 
 53 Keys to Staying Sharp 
  Version 2 
 
 
Page 53 of 58  
 expectations about the assigned condition were significantly related to composite outcomes  of CAP and cogni-
tion. However, having greater expectations that the randomized condition would positively affect abilities  was 
associated with poorer performance. See Table 2. Additional sensitivity analyses examined if there were differ-
ential effects by sex. No significa nt group- time-sex interactions were evident ( ps>.119) , and the pattern of re-
sults was the same when analyses were stratified by sex.   
 54 Keys to Staying Sharp 
  Version 2 
 
 
Page 54 of 58  
  
Table 14.1. Participant characteristics by randomized arm and cognitive  status . 
 Piano  Training  Music List ening  
Cogni tive status  Non-MCI  
M (SD) MCI  
M (SD) Non-MCI  
M (SD) MCI  
M (SD) 
 
n (%) n (%) n (%) n (%) 
Age in years  69.1 (5.5)  71.4 (7.1) 69.6 (5.2)  72.1 (5.7)  
Education in years  16.0 (2. 3) 16.5 (2.2) 16.0 (2. 1) 15.4 (2. 3) 
Sex (% female)  63 (65%)  18 (48% ) 58 (59%)  17 (44%)  
Music Reading Assessment 
score (/ 40) 2.52 (4.31) 2.43 (3.83) 3.42 (5.41)  2.08 (4.29)  
Montreal Cognitive Assessment 
score (/30)  26.6 (2.1)  23.3 (1.4)  26.6 (1.9)  22.8 (1.6)  
Geriatric Depression Scale  
short -form  score (/ 15) 0.9 (1.2)  1.1 (1.1)  0.9 (1.1)  0.6 (0.9)  
Pure tone average  left ear (dB)+ 19.8 (9.4)  20.4 (9. 4) 20.9 (10.8)  27.7 (15.9)  
Pure tone average r ight ear 
(dB)+*  18.6 (10. 3) 20.4 (9.9) 22.4 (14.0)  25.8 (11.6)  
Visual acuity (logMAR)+*  .04 (.12)  .09 (.15)  .01 (.13)  .01 (.10 ) 
Expectati ons (rating/7)*  5.4 (1.2)  5.8 (0.8)  4.9 (0.8  5.3 (0.8)  
Note.  MCI=mild cognitive impairment. +Lower scores reflect better performance. *Significant differences 
by randomized group were evident in pure tone average right ear, visual acuity, and expectation s (ps<.01). 
 55 Keys to Staying Sharp 
  Version 2 
 
 
Page 55 of 58  
  
Table 14.2. The effects of randomization to  piano training as compared to music listening  from 
baseline to post- training across  composite outcomes of central auditory processing, cognition, 
and everyday function.  
 Estimate  SE p 
 Estimate  SE p 
 ATTR+    Central auditory processing  
Intercept  53.90  1.17 <.001    46.25  0.73 <.001  
Group  -2.24 2.37 .346   -1.72 1.49 .249 
Time  -2.77 0.68 <.001    2.29 0.36 <.001  
Group x time  1.51 1.35 .265   .465 0.71 .515 
Hearing  0.12 0.06 .030   -0.63 0.04 <.001 
Visual acuity  6.24 4.71 .187   -7.270  3.97 0.07 
Expectations  0.79 0.59 .185   -1.20 0.49 .016 
  Verbal fluency    Cognition  
Intercept  49.32  0.98 <.001    51.81  0.90 <.001  
Group  -1.81 2.00 .367   -2.62 1.84 .157 
Time  0.41 0.48 .393   -1.40 0.42 .001 
Group x time  -0.29 0.96 .763   0.39 0.84 .638 
Hearing  -0.09 0.06 .134   -0.14 0.06 .016 
Visual acuity  -6.55 5.33 .220   -15.45  5.12 .003 
Expectations  -0.79 0.67 .234   -1.96 0.64 .003 
 Timed IADL+    Test of Everyday Attention  
Intercept  48.89  1.32 <.001 
 62.34  1.15 <.001  
 56 Keys to Staying Sharp 
  Version 2 
 
 
Page 56 of 58  
 Group  3.15 2.67 .240 
 1.37 2.33 .557 
Time  0.14 0.79 .863 
 -8.61 0.67 <.001  
Group x time  -1.53 1.58 .327 
 -0.40 1.340  .765 
Hearing  0.07 0.57 .194 
 -0.02 0.05 .603 
Visual acuity  12.75  4.770  .008 
 0.24 4.470  .957 
Expectation s 1.02 0.59 .089 
 -0.79 0.56 .157 
Note .  ATTR=Adaptive Tests of Temporal Resolution, IADL= instrumental activities of daily 
living.  MCI=mild cognitive impairment. +For ATTR and Timed IADL lower scores reflect 
better performance.  
 
 57 Keys to Staying Sharp 
  Version 2 
 
 
Page 57 of 58  
 Table 14.3.  Effect sizes for pi ano training relative to music listening across composite outcomes and assess-
ments for the analytic sample overall, among those adherent, and by cognitive status . 
Outcome Measure  d Effect Size  
  
Overall  
(n=198)   
Adherent  
(n=189)  Non-
MCI  
(n=146)   
MCI  
(n=52 ) 
Central auditory processing composite  -0.01 -0.01 0.00 -0.07 
   Dichotic Digits  -0.06 -0.07 -0.03 -0.14 
   Dichotic Sentence Identification  0.01 0.01 0.02 -0.07 
   Time Compressed Speech  -0.01 0.01 0.03 -0.06 
   Words in noise  0.03 0.03 0.12 0.01 
Adaptive Tests of Temporal Resolution compo-
site 0.17 0.20 -0.09 0.24 
Cognitive composite  -0.03 -0.03 -0.10 0.08 
   Trails A  0.03 0.06 0.00 0.43 
   Trails B  -0.17 -0.20 0.01 -0.54 
   Digit Symbol Coding  0.08 0.09 0.06 0.26 
   Test of Everyday Attention - Visual elevator 
timing subtest  0.02 0.02 0.03 0.44 
   Test of Everyday Attention - Telephone search 
time -0.29 -0.32 0.08 -0.27 
Verbal fluency composite  0.05 0.06 0.09 -0.12 
 58 Keys to Staying Sharp 
  Version 2 
 
 
Page 58 of 58  
    Letter fluency  0.00 0.02 0.09 -0.36 
   Category fluency  0.18 0.20 0.18 0.13 
   Switching fluency  -0.06 -0.05 -0.07 -0.05 
Test of Everyday Attention composite  0.04 0.08 -0.30 -0.02 
    Visual Elevator accuracy  0.01 0.03 -0.12 -0.19 
    Dual task decrement  0.10 0.13 -0.18 0.22 
Timed Instrumen tal Activities of Daily Living 
composite  -0.15 -0.21 0.09 -0.13 
Note .  MCI=mild cognitive impairment.  d effect sizes were calculated as pre-  to post - change in the piano train-
ing condition relative to the music listening condition divided by the baseline  standard deviation such that posi-
tive values would indicate improvement.  Adherent analyses include thos e who completed 15 or more sessions 
of the assigned condition.  
 